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Bioinformatics is an important area to analyze the massive biological data and predict 
the biological meanings using computational and statistical methods. Since the 
massive and highly qualified data have been accumulated by development of 
microarray technology, researches for finding biological meanings through predicting 
gene functions and transcriptional regulatory elements by using bioinformatical 
approaches are actively progressed. In these studies, we show the predicted and 
confirmed results for gene function and transcriptional regulatory element through two 
examples, selenophosphate synthetase 1 (SPS1) and microRNA genes. 
For example predicting gene function, we used SPS1 which functions are 
unknown yet. There are two selenophosphate synthetases (SPSs) in higher eukaryotes, 
SPS1 and SPS2. Of these two isotypes, only SPS2 catalyzes selenophosphate 






found to be essential for cell growth and embryogenesis. The function of SPS1, 
however, has not been elucidated. Using microarray data from obtained SPS1 
knockdown, differentially expressed genes were identified using two-way analysis of 
variance methods and clustered according to their temporal expression pattern. Gene 
ontology analysis was performed against differentially expressed genes and gene 
ontology terms related to vitamin B6 biosynthesis were found to be significantly 
affected at the early stage (day 3). Interestingly, genes related to defense and amino 
acid metabolism were affected at the later stage (day 5) following knockdown. Levels 
of pyridoxal phosphate, an active form of vitamin B6, were decreased by SPS1 
knockdown. Treatment of SL2 cells with an inhibitor of pyridoxal phosphate synthesis 
resulted in both a similar pattern of expression as that found by SPS1 knockdown and 
the formation of megamitochondria, which is the major phenotypic change observed 
by SPS1 knockdown. These results indicate that SPS1 regulates vitamin B6 synthesis, 
which in turn impacts various cellular systems such as amino acid metabolism, 
defense and other important metabolic activities. 
For example for predicting transcriptional regulatory elements, we selected 
miRNA genes. miRNAs are important post-transcriptional regulators of various 
biological processes. Although our knowledge of miRNA expression and regulation 
has increased considerably in recent years, the regulatory elements for miRNA gene 
expression, especially for intergenic miRNAs, are not fully understood. We identified 
the differentially methylated regions (DMRs) occurring 1000 bp upstream from all 
miRNAs in human neuroglioma cells using microarrays and discovered a unique 
sequence motif C[N]6CT. This motif was preferentially located within 400 bp or from 






methylated region. Interestingly, treatment of cells with a methyl transferase inhibitor 
(5-aza-2-deoxycytidine, DAC) significantly increased expression of miRNA genes 
with a high frequency of the C[N]6CT motif in DMRs. Statistical analysis showed that 
the frequency of the C[N]6CT motif in DMRs is highly correlated with intergenic 
miRNA gene expression, suggesting that C[N]6CT motifs associated with DNA 
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1. BIOINFORMATICAL APPROCHES FOR EXPRESSION DATA 
1.1. DNA microarray technology 
 DNA microarrays can simultaneously measure the expression level of 
thousans of genes within a specific sample. DNA microarray technology which is 
evolved from Southen blot is invented by Stephen P.A. Foder and colleagues in 1989 
(Fodor et al., 1993; Pease et al., 1994). Microarrays are composed of short DNA 
probes which are implemented on a glass slide (Maskos et al., 1992). The sequences 
of probes in array lattice are complementary to those of the interested genes, called 
target (Schena et al., 1995). Targets prepared from samples are labeled with 
fluorescent dye and annealed with the probes on a glass slide (Figure 1.1).  
 Microarrays can be classified into two types according to the number of 
samples that can be applied on single array (Brown et al., 1999); two-channel 
microarray and one-channel microarray (Figure 1.2).  Two-channel microarrays are 
hybridized with cDNAs prepared from two samples to be compared. cDNAs are 
labeled with two different fluorescent dyes, Cyanin 3 (Cy3) and Cyanin 5 (Cy5), 
respectively. Cy3 emits a wavelength of 570 nm which is corresponding to the green 
part of the light spectrum, and Cy5 emits wavelength of 670 nm which is 
corresponding to the red part of the light spectrum. The two Cy-labeled cDNAs are 
mixed and hybridized to a single array chip, and then that is scanned in a platform-
specific scanner to detect the fluorescences (Shalon et al., 1996). Relative intensities 
of each fluorescent dye are used in ratio-based analysis to identify up-regulated and 
down-regulated genes (Tang et al., 2007). In one-channel microarrays or single-
channel microarray, cDNAs prepared from each sample are labeled with only single 
2
Figure 1.1. General procedure of microarray (from Duggan et al., 1999) 
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dye and the labeled cDNAs are hybridized to each uniformative microarray chip, 
respectively (Patterson et al, 2006). For these reasons, the single-channel microarray 
system has the advantages that an aberrant sample cannot affect the raw data derived 
from other samples and that array data from different experiments are more easily 
compared to each other. However, one-channel microarray system requires twice more 
array chips compared to two-channel microarray system (Jaluria et al., 2007).  
1.2. Applications of microarray 
 Microarrays are widely used to various biological researches, including gene 
expression profiling, chromatin immunoprecipitation on chip (ChIP-on-chip), 
detection of single nucleotide polymorphisms (SNPs), alternative spliced transcripts 
and fusion genes, and tiling array (Stoughton, 2005). The most well known use of 
microarrays is for profiling gene, especially messenger RNA (mRNA), expression 
levels (Shiu et al., 2008). To identify the differential expressed genes (DEGs) affecting 
in diseases or developmental stages of model animals, tens of thousands of DNA 
probes complementary to target DNAs are implemented on a array chip and the 
intensities of probes are measured simultaneously. Microarrays techonology have also 
been used to detect binding sites of DNA-protein interactions, called ChIP-on-chip. 
ChIP-on-chip technique which combines chromatin immunoprecipitation with 
microarray technology is generally used for identifying the binding sites of 
transcription factors or histone, and the methylated sequences of the genome (Zheng et 
al., 2007). To identify SNP among alleles within or between populations (McCarroll et 
al., 2008), potential splice sites of predicted exons for a gene (Milani et al., 2006), and 
fusion transcripts from cancer species (Jones et al., 2008), microarrays technology can 
5
be applied. Genomics tilling arrays consist of overlapping probes designed to densely 
represent a genomics region of interest or as large as entire region of human 
chromosome (Ishkanian et al., 2004). The purpose is to empirically detect expression 
of trasciprits or alternatively splice forms which may not have been previously known 
or predicted (Mockler et al., 2005). 
1.3. Microarray data analysis 
1.3.1. Standardization of microarray data 
 Since the data obtained from microarray experiment are very complicated 
and multi-dimensional structure, it is difficult to use the data among researchers. 
Therefore, biologists defined the guideline for microarrays, called the minimum 
information about a microarray experiment (MIAME), in 1999 to easily transfer and 
share the microarray data. The MIAME guidelines include a description of the 
following six sections (Brazma et al., 2001).  
 1. Experimental design: the set of hybridization experiments as a whole 
 2. Array design: each array used and each element (spot, feature) on the array 
 3. Samples: samples used, extract preparation and labeling 
 4. Hybridizations: procedures and parameters 
 5. Measurements: images, quantification and specifications 
 6. Normalization controls: types, values and specifications 
For example, the information required to describe the measurement for a particular 
gene in a particular sample can be divided conceptually into three parts including gene 
annotation, sample annotation and a gene expression matrix (Figure 1.3).  
6
Figure 1.3. Conceptual view of ge
three parts: (i) gene annotation, w
sequence databases, (ii) sample an
no public external databases (excep
gene expression matrix, in which
characterizing the expression of a p
(from Brazma et al., 2001).
ne expression data. The model has
hich may be given as links to gene
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articular gene in a particular sample
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1.3.2. Pre-processing of microarray data 
 Before microarray data analysis, several pre-processing steps are required. 
First, images are scanned to determine the signal intensity of each spot. This is usually 
done by image scanning software for a specific microarray platform such as GenePix 
(Fielden et al., 2002), ImaGene (Medigue et al., 1999), GeneSpring (Agilent 
Technologies, Palo Alto, CA), and many more (Bengtsson et al., 2006). Second, 
normalization has to be performed to remove dye-related bias between two channels 
and various slide-specific artifacts that can exist between different microarrays. After 
pre-processing, the normalized microarray data can be further analyzed using various 
computational analysis methods such as clustering techniques and gene ontology 
analysis approaches. 
1.3.3. Normalization 
 When performing microarray experiments with multiple slides, non-
biological variations are always exist between arrays such as dye biases, probes 
printing variations, and volume of initial RNA. To correct these variabilities, a series 
of normalization steps has to be performed with the scanned data before analysis. The 
main assumption behind normalization process is that most of the genes do not change 
their expression levels, and numbers of up- and down-regulated genes on each array 
are nearly equal. Overall average expression level of genes remains the same among 
different arrays. Thus, most normalization methods try to adjust expression levels of 
the genes by removing saturated signals from microarray or correcting the signal with 
background and probe spots.  
8
 Generally, when the signal intensities of genes is computed as the ratio 
between two hybridization signal, those of the over-expressed genes is greater than 1, 
and those of repressed genes is between 0 to 1. For these reasons, the signal intensities 
are transformed into the 2-based-logarithm to generate symmetrical distribution of the 
data and provide more interpretable comparisions between genes (Quackenbush et al., 
2002). 
 For one-channel microarrays such as Affymetrix arrays, robust multi-chip 
average (RMA) is used for background correction by calculating the average value of 
perfect match (PM) intensities (Irizarry et al., 2003), and then quantile normalization 
is performed to adjust all probes intensities. Quantile normalization is based on the 
idea the the distribution of two array data is the same if the quantile-quantile 
associated plot is a straight diagonal line that we can represent by the unit vector 
(Balstad et al., 2003). Quantile normalization process normalizes data by aligning 
ranked columns, computing their mean, and then replacing the the original data with 
the average quantiles (Figure 1.4).  
 In two-channel microarrays, many different methods have been developed to 
correct for dye-effects and other systematic errors between arrays. For example, global 
normalization (Quackenbush et al., 2002) is the simplest methodology to adjust all 
log2-transformed measurements equal to zero. There are other methods that use 
similar global normalization approach, including log centering, rank invariant methods 
(Tseng et al., 2001), and many other variations. However, these methods are 
inadequate in situations where systematic noise depends on overall intensity or spatial 
location within the array (Yang et al., 2001). To account for these problems depends 
on the intensity and spatial location, lowess normalization methods based on robust 
9
Figure 1.4. Concept of quantile normalization
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local weighted regression (Cleveland et al., 1988) have been proposed. This method 
adjusts the ratios through locally linear fits that depend on the intensity and has been 
proven to be a powerful normalization method for different types of two color 
microarray experiments (Berger et al., 2004). Although many new methods (Baird, et 
al., 2004; Chua et al., 2006; Wang et al., 2004; Yoon et al., 2004) and modifications 
(Wang et al., 2005) have been proposed, the comparison results are inconsistent and 
new methods outperform lowess normalization only in special cases (Fujita et al., 
2006).  
1.3.4. Statistical methods 
 Fold change (FC) was one of first methods used to identify differentially 
expressed genes (DEGs) between two different experimental conditions, such as 
samples or time points because of its simplicity. However, the method does not 
provide several questions; confidence intervals for results, and potential high false 
discovery rate (FDR) of results (Budhraja et al., 2003; Hsiao et al., 2004). For these 
reasons, more stringent statistical approaches have been suggested for microarray 
analysis. Among these, Student’s t-test, analysis of variance (ANOVA), Mann-
Whitney-Wilcoxon rank test, and significance analysis of microarray (SAM; Tusher et 
al., 2001) are most popular methods.  
 Student’s t-test is used to test the hypothesis that a gene’s expression levels 
differ between two sets of samples by using the T statistic and determining the 
significance level of the difference from t distribution (Gossett, 1908). This test is 
based on two assumption between two samples to be compared; the assumptions of 
normality and equal variance (Gossett, 1908). 
11
 ANOVA uses Fisher’s F-distribution as part of the test of statistical 
significance and compares group variations to the overall variation observed (Kerr et 
al., 2000). One-way ANOVA method was most widely used for microarray data 
analysis. Recently, since more complicated experimental designs have been 
introduced with more than two independent variables, such as comparison with two 
samples according to several time points, two-way ANOVA method is also widely 
used (Churchill et al., 2004; Pavlidis et al., 2003).  
 Two-way ANOVA is an appropriate analysis method for a study with a 
quantitative outcome and two or more categorical variables. It requires three main 
assumptions of normality, equal variance, and independent samples (Zar, 1999). The 
two possible models for two-way ANOVA are the additive model and the interaction 
model. The additive model assumes that the effects on the outcome of a particular 
level change for one variable does not depend on the level of the other variable. On 
the other hand an interaction model assumes that the effects of a particular level 
change for one variable depend on the level of the other variable. For examples, 
suppose that microarray experiment was performed with two different groups over 
three time points to indentify the t1 gene function, and t1 gene can affect the expression 
level of t2 gene. First, if the expression level and pattern of t2 gene is significantly 
differ between groups over time, then those of t2 gene is affected by the two variables, 
group and time, which means that the groups are changing over time (Time-by-group 
interactions; see in Figure 1.5A). Second, if the expression level of t2 gene is differ 
between groups, but the expression pattern of t2 gene in both groups is parallel without 
slope, then t2 gene is affected by only variable group (Group effect; see in Figure 
1.5B). Inversly, if the expression level of t2 gene is superimposed and the expression 
12
pattern of t2 gene is sloped, then t2 gene is affected by only variable time (Time effect; 
see in Figure 1.5C). Finally, if the expression level of t2 gene is differ between groups, 
and the expression pattern of t2 gene in both groups is parallel and slope, then t2 gene 
is affected by group and time (Group and time effect; see in Figure 1.5D) Overally, as 
shown in Figure 1.5, a plot drawn with parallel lines suggests an additive model, while 
non-parallel line suggests an interaction model. 
 SAM test is a statistical method for determining whether gene expression are 
significantly changed or not and uses slightly different statistic that is based on t-
statistic. This analysis performs the correction that reduces the relative differences for 
low expressed genes and genes with similar expression levels (Tusher et al., 2001). 
The input to SAM is gene expression measurements from a set of microarray 
experiments and a response variable, such as untreated and treated. SAM computes a 
statistic di for each gene i, measuring the strength of the relationship between gene 
expression and the response variable. It uses repeated permutations of the data to 
determine whether the expression of any genes is significantly related to the response. 
The cutoff for significance is determined by a parameter delta, chosen by the user 
based on the false positive rate (Tusher et al., 2001; http://www-stat.stanford.edu/). 
SAM test is a non-parametric statistics and more useful for analyzing non-normal 
distributed data.  
 Mann-Whitney-Wilcoxon rank test is also a non-parametric statistical test 
compares for each gene the difference between measurements in two groups. However, 
it does not require assumptions about the form of the distributions of the 
measurements, so it is more reliable when used on microarray data with large number 




















Figure 1.5. Models of two-way A
shows that each element inclu
expression patterns over time (T
represents only groups differences
Panel C represents superimposed p
Panel D shows that the elements



















NOVA for identifying DEG. Panel A
ded group A and B has different
ime-by-group interaction). Panel B
between two groups (group effect).
atterns between groups (Time effect).
of two groups are changed of their
ff t)up e ec
14
sizes, and provides poor significance levels for groups with fewer than 6 samples 
(Ahmad, 1996).  
1.4. Cluster analysis 
 Cells have adapted in different environmental conditions by responding a set 
of proteins required to use or oppose these conditions. To optimize the process, genes 
whose products function together are usually undergoing same regulatory mechanisms 
so they are coordinately expressed in response to stimuli. This property is used by 
many clustering methods that group genes together based on their expression profiles. 
In this case microarray data for analysis with clustering methods can be represented by 
a matrix with measurements of genes (rows) for multiple conditions (columns), where 
conditions can be of various kinds of samples, such as, different treatments, time 
points, and patients. Clustering algorithms can be divided into two categories: 
hierarchical clustering (Eisen et al., 1998) and non-hierarchical clustering such as k-
means clustering (Tibshirani et al., 1999) and self-organizing maps (SOM; Tamayo et 
al., 1999).  
1.4.1. Hierarchycal cluster 
 Hierarchical clustering is one of the first clustering algorithms applied to 
microarray data (Eisen et al., 1998; Alon et al., 1999; Cho et al., 1998). This method 
produces a classification by agglomeration in which small clusters of very similar 
molecules are agglomerated within larger cluster of less similar molecules. Using a 
distance metric, the method builds a hierarchical binary tree, called a dendrogram, 
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starting from the individual gene expression profiles as leaves by progressively 
merging clusters, where each internal node represents the average of its two children 
(Eisen et al., 1998). There are several hierarchical clustering methods according to 
measure distances between internal nodes, including single linkage, complete linkage, 
centroid linkage, median linkage and average linkage (Figure 1.6). The constructed 
tree can be cut at some point according to a threshold value to receive clusters of 
required characteristics. Due to its simplicity and clear representation, hierarchical 
clustering has been used in many reported microarray experiments, but a number of 
drawbacks should be considered. First, hierarchical clustering is a greedy search 
algorithm, meaning that merging decisions on early steps are based only on the 
distance between nodes and cannot be undone, but not necessarily the best ones in 
global scale and can lead to mistakes in the overall clustering. Second, dendrograms 
and corresponding heatmaps, which used extensively in visualizations of the analysis 
results, suffer from inversion problems that complicate interpretation of the hierarchy 
(Morgan et al., 1995). In addition, complexity of dendrograms for larger data sets 
makes them difficult to understand, and the choice of location for tree cut to receive 
final clusters is unclear. And finally, analysis of yeast cell-cycle dataset with 
hierarchical clustering performed by Cherepinsky et al. showed that the method has 
very low accuracy of gene assignments to clusters (Cherepinsky et al., 2003).  
1.4.2.Non-hierarchycal cluster 
 A non-hierarchical clustering generates a classification by partitioning a 
dataset, giving a set of non-overlapping groups having no hierarchical relationships 







Figure 1.6. Graphical examples
linkage (A), complete linkage (B),
(D), and average linkage (E) (mod
hs515.htm)
for inter-clusters distances Single
centroid linkage (C), median linkage
ified from http://www.multid.se/genex/
17
partition of k groups, and optimal k value is determined by heuristic or by repeated 
clustering result. The most well known approaches of non-hierarchical clustering are 
k-means algorithm (Tavazoie et al., 1999) and self-organizing maps algorithm 
(Kohonen et al., 1997). 
1.4.2.1. k-means clustering 
 The k-means clustering starts from randomly dividing genes into k groups 
and calculating cluster centers for each of these groups. New groups are formed by 
reassigning each gene to the closest centroid. Then the centroids are recalculated for 
the new clusters and the process repeats (Tavazoie et al., 1999). While simplicity and 
speed of the method are the main advantages of the method, the most important 
disadvantage is that results are not unique across different runs and depend on starting 
positions of centroids and the initial number of k. Another obstacle for analysis of 
microarray data is that this method finds sub-optimal clusters rather than optimal 
clusters from all data because of the limitation of k. Moreover, as it does not inform 
about the hierarchical structures among the data in each cluster, the similarity among 
the clusters are unknown (Heyer et al., 1999).  
1.4.2.2. Self-organizing maps (SOM) clustering 
 SOM which is proposed by Kohonen in 1997 is a type of artificial neural 
netork that use unsupervised learning to produce a lower-dimensional, usually two-
dimensional, representation of the input space of the traning data set samples 
(Kohonen et al., 1997). It performs the following procedure. After choosing an initial 
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grid of nodes the nodes are mapped randomly into k-dimensional space. At each step 
of the algorithm a random data point is chosen and nodes are moved in the direction of 
it. Nodes are moved depending on distance between a node and that data point, so the 
closest node is moved the most compared to more distant nodes (Figure 1.7).  
 Although a number of successful application of SOMs have been reported 
(Tamayo et al., 1999; Baker et al., 2001; Toronen et al., 1999), several disadvantages 
exist for the method. Sensitivity of SOM to incomplete data is a problem that is very 
important in microarray data analysis, due to abundance of missing data points 
resulting from data flagging during preprocessing (Tamayo et al., 1999). Also, a SOM 
can yield different decompositions of the data depending on the choice of initial 
conditions. Another issue is that initial node grid is fixed and may not be changed 
during the analysis, and that can lead to inappropriate mapping of the data space. In 
addition, when two data points are mapped from high dimensional space to nearby 
locations on the two dimensional grid, it is possible that those points are actually far 
apart in the higher dimensional space (Baker et al., 2001; Toronen et al., 1999). 
However, this method is widely used to analysis of microarray data which are 
obtained from a series of time point experiments because of the availability of their 
multi-dimensional clustering. For examples, if microarray experiments are performed 
with two samples in three time points, the grid configuration for SOM clustering can 
be set by 3x3 or 3x2 because the expression of gene can be measured to be increased, 
decreased or unchanged in early and late time point, respectively.   
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1.5. Gene Ontology(GO) analysis 
1.5.1. Foundation of GO 
 Biologists waste a lot of time and effort in searching for all of the available 
information about each small area of research because of the wide variations in 
terminology that may be common usage. For these reasons, the GO Consortium was 
founded to unify the biological terminology and the GO project was launched 
Ashburner et al., 2000). The GO project is a collaborative effort to address the need 
for consistent descriptions of gene products in different databases. The project began 
in 1998 as collaboration between three model organism databases; FlyBase 
(Drosophila; McQuilton et al., 2012), the Saccharomyces Genome Database (SGD; 
Cherry et al., 1998) and the Mouse Genome Database (MGD; Blake et al., 2003). 
Since then, the GO Consortium has grown to include many databases, including 
several of the world's major repositories for plant, animal and microbial genomes.  
1.5.2. Three categories of GO 
 The GO project has developed three structured controlled vocabularies 
(ontologies) that describe gene products in terms of their associated biological 
processes, cellular components and molecular functions in a species-independent 
manner.  
 Biological process refers to series of events to which the gene contributes. A 
process is accomplished via one or more ordered assemblies of molecular functions. 
They often involve a physical or chemical transformation, meaning that something 
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goes into a process and some other thing comes out of it. ‘Cell growth and 
maintenance’ or ‘signal transduction’ are some examples of high-level or broad 
biological process terms; whereas ‘translation’ or ‘pyrimidine metabolism’ are a 
couple of low-level or more specific biological process terms.  
 Cellular component refers to the place in the cell where a gene product is 
active. Its ontology describes locations, at the levels of sub cellular structures and 
macromolecular complexes. Cellular component includes terms, such as ‘ribosome’ or 
‘proteasome’ specifying where multiple gene products would be found. It also 
includes terms such as ‘nuclear membrane’ or ‘Golgi apparatus’.  
 Molecular function refers to the biochemical activity of a gene product and 
also the capability that a gene product carries as a potential. These may include 
transporting somethings, binding to somethings, holding with somethings and 
changing one into another. Examples of broad functional terms are ‘enzyme’, 
‘transporter’ or ‘ligand’. Examples of narrower functional terms are ‘adenylate cyclase’ 
or ‘toll receptor ligand’. 
 The structure of GO can be described in terms of a graph, where each GO 
term is a node, and the relationships between the terms are arcs between the nodes 
(Figure 1.8). The relationships used in GO are directed and the graph is acyclic, 
meaning that cycles are not allowed in the graph. The ontologies resemble a hierarchy, 
as child terms are more specialized and parent terms are less specialized, but unlike a 
hierarchy, a term may have more than one parent term. 
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1.5.3. Application of GO for functional genomics 
 Recently, GO analysis is an important step for identifying the function of the 
specific genes or gene products because massive data for gene expression obtained 
from microarray or high throughput sequencing experiment are accumulated. An 
approach making use of the GO for analyzing microarray experiments is that of 
Pavlidis et al in 2002. They suggested the method for scoring differential gene 
expression in groups of functionally related genes. The scoring method they proposed 
reflects the statistical significance of the expression pattern of each gene. Firstly, they 
calculate p-value for each gene by applying the analysis of variance (ANOVA) 
method on the gene specific expression values over the samples. And then, they 
calculate the experiment score by adding the negative logarithms of the ANOVA-p-
values of genes in specific GO group (Pavlidis et al., 2002). A second approach using 
the GO to analyze large-scale gene expression is to search for over-representation of 
particular GO categories from a list of genes. The over-represented GO category, or 
the most frequent GO category, is assigned as a major biological property in a gene 
cluster (Al-Shahrour et al., 2004). The hypergeometric test is generally implemeted as 
a statistical model for calculating over-represented GO categories in a gene cluster. 
The hypergeometric testing is a discrete probability distribution that describes the 
probability of i successes in n draws from a finite population of size N without 
replacement (Chvatal, 1979). In analyzing gene expression data, i successes indicate 
the number of genes showing that significantly different pattern of their expression. 
Then the hypergeometric probability is: 
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Notation is as follow: N is the number of total genes in a species, n is the number of 
genes identified as DEGs, k is the number of total genes included in a particular GO 




2.  SELENIUM BIOLOGY 
2.1. Selenium and human health 
Selenium is an essential trance element found in soil, and vegetables are the 
major dietary sources of selenium. The content of selenium in food depends on the 
selenium content of the soil where plants are grown or animals are raised. Selenium 
also can be found in some meats and seafood. Animals that eat grains or plants that 
were grown in selenium-rich soil have higher levels of selenium in their muscle. 
Selenium plays important roles for human health (Lee et al., 1996). Moderate 
selenium insufficiency may contribute to the pathogenicity of viral infection, the 
progression of AIDS in HIV positive patients, male infertility, and impaired immunity 
(Hatfield, Berry, and Gladyshev, 2006 and references therein; see Figure 1.9). 
Moreover, its deficiency has been implicated as a factor in Keshan disease, a 
cardiomyopathy that affects young women and children in certain regions of China 
that have selenium-poor soil. Since dietary selenium reduces the risk of certain types 
of cancers (Clark et al., 1996), selenium has also sparked a lot of interest as an 
anticancer nutrient. 
Selenium has also attracted the attention of molecular biologists because it is 
co-translationally incorporated into protein as the amino acid selenocysteine (Sec), the 
21st amino acid (Lee et al., 1989; Longtin, 2004). Sec is encoded by a UGA codon in 
selenoprotein mRNA (Hatfield and Gladyshev, 2002; Birringer et al., 2002; Driscoll 
and Copeland, 2003; see Figure 1.10). Sec is widely used in all major domains of life 
and is responsible for the majority of biological effects of selenium. There are 25 
known selenoproteins in humans and 24 in rodents (Kryukov et al., 2003). Therefore, 
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it is very important to understanding how selenium is incorporated into protein and the 
biological functions of the selenoproteins.  
2.2. Selenium metabolism 
Selenium metabolism from selenium supplements indicates differences in the 
absorption and use of selenium between inorganic and organic forms in humans 
(Butler et al., 1999; Brown et al., 2000) and rats (Finley et al., 2001). The absorption 
pathways have not yet been fully characterized; however, selenium as selenate or 
selenite appears to be very well absorbed but less well retained in the body than 
organic forms of selenium, such as selenomethionine and Sec (Schrauzer et al., 2000). 
The proposed metabolic pathways for different forms of selenium are shown in Figure 
1.11 (Fairweather-Tait et al., 2010). Selenomethionine, Sec, selenate, and selenite 
enter the selenide pool and the selenium is either used for selenoprotein synthesis or 
excreted in the urine as a selenosugar. Selenomethionine can be incorporated directly 
into proteins through the replacement of methionine; however, optimal and suboptimal 
levels in diet, selenium mainly transformed into Sec in animals, and then Sec is 
incorporated into selenoproteins. Therefore, deficiency in dietary selenium results in 
decreased levels of selenoproteins and biological processes that are maintained by 
selenoproteins are compromised. 
2.3. Selenoproteins biosynthesis 
Most of the characterized selenoproteins are enzymes involved in oxidation 
reduction reactions and contain Sec in their active site (Stadtman, 2000). Sec is 
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structurally very similar to serine (Ser) and cytosine (Cys), except that it contains 
selenium instead of oxygen and sulfur, respectively (Figure 1.12). Since the selenol 
group is more fully ionized than the thiol group at physiological pH (Stadtman, 1996), 
the catalytic activity of a selenoprotein is strongly decreased after Sec is replaced with 
Cys (Axley et al., 1991). Although there are no known selenoproteins in higher plants, 
or in yeast, the majority of organisms have selenoproteins. 
The selenoproteins play crucial roles in a variety of biological processes, and 
several of them are involved in antioxidant defense. Glutathione peroxidases (GPx) 
protect cells against peroxidative damage by reducing hydrogen peroxide and free 
fatty acid hydroperoxides (Flohe and Brigelius-Flohe, 2001). Another GPx family 
member, phospholipid hydroperoxide glutathione peroxidase (PHGPx), reduces 
phospholipid, cholesterol, and cholesteryl ester hydroperoxides, thereby protecting 
cells against membrane lipid peroxidation (Flohe and Brigelius-Flohe, 2001). PHGPx 
also plays a structural role in the mitochondrial capsule of mature spermatozoa where 
the protein becomes oxidatively cross-linked and inactive (Ursini et al., 1999). This 
noncatalytic function of PHGPx may also be involved in the male infertility similar to 
selenium deficiency (Flohe, 2001). In mammals, three distinct mammalian thioredoxin 
reductases function in cellular redox homeostasis by reducing thioredoxin and other 
substrates (Holmgren, 2001). Other oxido-reductases that contain Sec include the 
family of deiodinases, which are involved in thyroid hormone metabolism (Germain, 
2001), and selenophosphate synthetase 2 (SPS2), which synthesizes the selenium 
donor for Sec biosynthesis. This enzyme is unique in that it is the only selenoprotein 
expressed in both prokaryotes and eukaryotes (Guimaraes et al., 1996). 
There are several selenoproteins, including SelW, which is expressed in 
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cardiac and skeletal muscle (Whanger et al., 2002), and Sep15, which is implicated in 
preventing prostate cancer (Gladyshev, Diamond and Hatfield, 2001). Novel 
selenoprotein genes have been identified in the human genome using bioinformatic 
approaches, but the functions of the encoded proteins are largely unknown. One of 
these selenoproteins, SelR, was shown to be a methionine sulfoxide reductase 
(Kryukov et al., 2002). An antioxidant function has also been proposed for the plasma 
protein, selenoprotein P (SelP). The SelP mRNA encodes 10 to 17 UGA codons, 
depending on the species (Burk and Hill, 2005). Understanding how multiple UGA 
codons are decoded as Sec in SelP would provide important insight into the 
mechanism of selenoprotein synthesis.  
2.3.1. Mechanism of selenocysteine biosynthesis 
Selenocysteine is known as the 21st amino acid in protein synthesis (Lee et al., 
1989; Longtin, 2004) and its specific incorporation is directed by the UGA codon. 
Because UGA codon can recognized as a Sec codon as well as a stop codon, the 
cellular mechanisms that distinguish between these two functions exist. Unique tRNA, 
called Sec-tRNA[Ser]Sec, that have complementary UGA anticodons, and several factors 
have been identified for being required in the recognition of UGA as Sec codon.  
The mechanisms of Sec biosynthesis are slightly different between 
prokaryotes and eukaryotes. In prokaryotes, Sec is directly synthesized by replacing 
the hydroxyl moiety of serine into selenium moiety on serine charged tRNA[Ser]Sec 
(Forchhammer and Böck, 1991). In eukaryotes, one more enzyme is involved in Sec 
synthesis. tRNA[Ser]Sec is first aminoacylated with serine by Seryl-tRNA[Ser]Sec 





































by O-phosphoseryl-tRNA[Ser]Sec kinase (PSTK; Carlson et al., 2004) to yield 
Phosphoseryl-tRNA[Ser]Sec, which is converted to Sec-tRNA[Ser]Sec by selenocyteine 
synthase (SecS) (Yuan et al., 2006; Xu et al., 2007). Sec-tRNA[Ser]Sec is used on the 
ribosome to insert Sec into a specific site in a nascent polypeptide of selenoproteins. 
The active donor of selenium in Sec biosynthesis is monoselenophosphate (Glass et al., 
1993), which is synthesized from selenite and ATP by an enzyme designated as 
selenophosphate synthetase (SPS; Ehrenreich et al., 1992).  
2.3.2. Incorporation of selenocysteine into protein 
One novel feature of selenoprotein mRNAs is the occurrence of a cis-stem-
loop structure known as the SEC Insertion Sequence (SECIS) element or elements in 
the 3’-untranslated region (3’-UTR) of selenoprotein mRNAs (Low and Berry, 1996). 
SECIS elements are responsible for recoding the UGA codon as Sec and bypassing 
stop. In addition to these two cis-acting factors, there are several trans-acting factors 
involved in the insertion of this amino acid into protein: selenocystenyl-tRNA[Ser]Sec-
specific elongation factor, EFsec (Tujebajva et al., 2000; Fagegaltier et al., 2000); 
SECIS-binding protein, SBP2 (Copland et al., 2000); and L30 ribosomal protein, 
rpL30 (Chavatte et al., 2005).  
Mechanism of selenocysteine incorporation into protein is summarized in 
Figure 1.14 (Hatfield and Gladyshev, 2002). After seryl-tRNA[Ser]Sec residue is 
converted to a selenocysteine-residue by the PLP-dependent enzyme selenocysteine 
synthase (SecS), selenocysteyl-tRNA[Ser]Sec is incorporated into ribosomal A-site 
mediated by a specific translational elongation factor, eEFsec, and SECIS binding 
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selenocysteyl-tRNA[Ser]Sec is transferred to the peptidyl site and Sec is incorporated 
into the nascent selenopeptide.  
2.3.3. Components of selenocysteine biosynthesis 
The SECIS element is a stem-loop and cis-acting RNA structure around 60 
nucleotides in length on the 3’ UTR of selenoprotein mRNA transcripts. This 
structural motif serves as the signaling factors for translating UGA stop codon as Sec 
(Low and Berry, 1996). Thus, SECIS elements are a fundamental aspect of mRNA 
encoding selenoproteins. Eukaryotic SECIS elements are composed of two helices 
separated by an internal loop, a SECIS core structure consist of a Quartet located at 
the base of helix 2, and an apical loop or bulge (Figure 1.15). The Quartet is specific 
base pairs composed of four non-Watson-Crick types. It appears to be the main 
functional site of the stem-loop structure when binding to SBP2 and the L30 protein. 
There is a spatial requirement regarding the distance between in-frame Sec UGA 
codon and 3’UTR SECIS elements. The minimal distance was measured to be 
between 51 and 111 nucleotides (Low and Berry, 1996), suggesting that SECIS 
elements are both necessary and sufficient for Sec insertion. In bioinformatics, several 
computer programs have been created that search for SECIS elements within a 
genome sequence, based on the sequence and secondary structure characteristics of 
SECIS elements (Chapple et al., 2009).  
Elongation factor for selenoprotein translation (eEFsec), which is also called 
eSelB, is necessary translation factor for the incorporation of Sec into nascent 
polypeptides in response to UGA codon by recruiting selenocystenyl-tRNA and acting 
with SBP2 (Tujebajeva et al., 2000; Fagegaltier et al., 2000). eEFsec is specific for 
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Sec and does not bind seryl-tRNA[Ser]Sec (Tujebajeva et al., 2000) or phosphoseryl-
tRNA[Ser]Sec (Carlson et al., 2004). eEFsec forms a complex with SBP2 and this 
complex formation is stimulated by the presence of selenocystenyl-tRNA[Ser]Sec. 
SBP2, is factor appears to have essential functions that include binding to the 
SECIS core and the ribosome, and the insertion of Sec into selenoprotein. SBP2 binds 
the Quartet in SECIS element to form SBP2-SECIS complex (Driscoll et al., 2003; 
Copeland, 2003). SBP2 also binds to the ribosome at the 28S RNA by binding with 
one or more kink turn structures (Kinzy et al., 2005). rpL30 also enhances the 
incorporation of Sec into protein (Chavatte et al., 2005). A model to accommodate the 
participation of both components in binding to the SECIS element has been proposed 
wherein SBP2 and rpL30 carry out different functions in the recoding of UGA and the 
SECIS element acts as a molecular switch upon protein binding (Chavatte et al., 2005). 
SBP2 is continually bound to the ribosome except at the time Sec is delivered to the 
A-site for decoding (Caban et al., 2006; Kinzy et al., 2005). Thus, SBP2 can serve to 
select a subset of ribosome and program them for Sec insertion competence by 
interacting with the SECIS element at the moment of Sec insertion. The role of rpL30 
would then be to compete SBP2 off the SECIS element and back onto the ribosome, 
rendering the ribosome competent for another round of recoding (Caban et al., 2006) 
2.4. Selenophosphate synthetase (SPS) 
Selenophosphate synthetase (SPS) is the enzyme that catalyzes the formation 
of monoselenophosphate, which is the active selenium donor, from selenide and ATP 
(Glass et al., 1993). In lower eukaryotes and bacteria, there is only one type of SPS 
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encoded by SelD gene; however, there are two isoforms of SPS in higher eukaryotes, 
SPS1 and SPS2 (Leinfelder et al., 1990; Guimaraes et al., 1996).  
2.4.1. Structural characteristic of eukaryotic SPS  
Although there are two types of SPS, or SPS1 and SPS2, in higher eukaryotes, 
the DNA sequences homology between SPS1 and SPS2 is different each other. 
Whereas the amino acid sequence homology has high similarity between them. For 
examples, the amino acid sequence homology between Drosophila SPS1 and SPS2 is 
approximately 45%, and that between human SPS1 and SPS2 is 72%. There are two 
well conserved motifs among two isoforms (Figure 1.16). As shown in Figure 1.16, 
motif A is similar to the consensus sequence for ATP binding site, and it contains well 
conserved Lys 20 residues. Biochemical analysis with E.coli SelD mutants shows that 
selenide-dependent formation fo AMP from ATP was dramatically reduced by 
replacement Cys 17 and Lys 20 to others (Kim et al., 1992; 1993). These results 
indicate that Cys 17 and Lys 20 positions are essential active sites for the formation of 
selenophosphate. However, Cys 17 residue is substituted to threonine (Thr) and 
arginine (Arg) in human (also mouse) and Drosophila SPS1, respectively. In contrast, 
SPS2 is a selenoprotein with Sec (U) substituted at the same site (Guimaraes et al., 
1996). Motif B is a conserved glycine rich region similar to the conservd ATP/GTP 
binding consensus sequences, GXXXXGK(S/T) or GXGXXG found in many 
ATP/GTP binding proteins or protein kinases, respectively (Low et al., 1995; 
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2.4.2. Functional characteristics of eukaryotic SPS 
Both SPS1 and SPS2, homologous genes of SelD, were initially proposed to 
contain a catalytic activity in selenophosphate synthesis (Low et al., 1995; Guimaraes 
et al., 1996). In the earlier time, Tamura and colleagues had proposed that both SPS1 
and SPS2 were able to synthesize selenophosphate by different pathways. When 
cDNA of SPS1 from human lung adenocarcinoma was cloned and transformed into a 
SelD deficient mutant of E.coli, the SelD mutation was not complemented in selenite 
containing medium, but complemented when the cells were cultured in the medium 
supplemented with L-selenocysteine (L-Sec; Tamura et al., 2004). From these finding, 
it was proposed that SPS1 might be able to synthesize selenophosphate by recycling 
intracellular L-Sec through salvage pathway (Figure 1.17). However the mechanism of 
Sec recycling and how SPS1 regulates Sec recycling have not yet been determined. 
On the other hand, there are some evidences that SPS1 does not participated 
in selenophosphate synthesis. Drosophila SPS1 purified from the overexpression in 
E.coli did not catalyze the selenide-dependent ATP hydrolysis reaction and its gene did 
not complement a SelD lesion in E.coli. Recently, it was subsequently shown that only 
SPS2 catalyzes selenophosphate synthesis. In vitro experiments, SPS2 synthesized 
selenophosphate from selenide and ATP, but SPS1 did not have this activity (Xu et al., 
2007a). Knockdown of SPS2 in NIH3T3 cells led to the loss of selenoprotein 
biosynthesis, whereas the inhibition of SPS1 expression did not affect the biosynthesis 
of selenoproteins, and only SPS2 was capable of restoring selenoprotein synthesis (Xu 
et al., 2007b). In some insects such as the red beetle and silkworm, which have lost the 
selenoprotein synthesizing machinery, including SPS2, SPS1 still encoded in the 
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Although SPS1 does not participate in the synthesis of selenophosphate, it 
has an essential function in Drosophila as the knock-out of the gene encoding SPS1, 
designed patufet, led to aberrant imaginal disc morphology and embryonic lethality 
(Alsina et al., 1998). The null mutation of patufet caused an accumulation of ROS and 
suggesting SPS1 plays a role in reducing the intracellular ROS level (Morey et al., 
2003). Haplo-insufficiency of patufet dominantly suppressed the phenotypes caused 
by hyperactivation of the Ras/mitogen-activated protein kinase (MAPK) cassette, and 
the activation of the Drosophila epidermal growth factor receptor and Sevenless 
receptor tyrosine kinases (Morey et al., 2001). These evidences suggest that SPS1 may 
have novel function unrelated to selenophosphate synthesis, but related with important 
signaling pathway as well as cell growth.  
  
44
3.  VITAMIN B6 
Vitamin B6 is a water-soluble compound and is part of the vitamin B complex 
group (Combs, 2008). There are several forms of the vitamin, such as pyridoxine (PN), 
pyridoxine 5’-phosphate (PNP), pyridoxal (PL), pyridoxal 5’-phosphate (PLP), 
Pyridoxamine (PM), and pyridoxamine 5’-phosphate (PMP). The structures of vitamin 
B6 are summarized in Figure 1.18.  
3.1. Physiological roles of vitamin B6  
PLP, the metabolically active form of vitamin B6, is involved in the variety of 
macronutrient metabolism, including neurotransmitter, histamine and hemoglobin 
synthesis. Moreover, PLP generally served as a cofactor for many biological processes 
and can help facilitate decarboxylation, transamination, racemization, and replacement 
and –group interconversion reactions (Grogan, 1988; Mihara et al., 1997). 
PLP is a cofactor in transaminases in amino acid metabolism (Dolphin et al., 
1986; Dakshinamurti, 1990). It is an essential component of two enzymes involved in 
cysteine and selenocysteine metabolism, or cystathionine –synthase (CBS) and 
cystathionine –lyase (CBL). In cysteine metabolism, CBS catalyzes to produce L-
cystathionine, which is a precursor compound to be L-cysteine, from L-homocysteine 
and L-serine as substrates (Banerjee, 2005). CBL converts L-cystathionine to L-
homocysteine in cysteine catabolism, and also L-selenocystathionine to L-
selenohomocysteine in selenocysteine metabolism (Mihara et al., 1997; Anderson et 
al., 1979; Flavin and Slaughter 1964). Selenohomocysteine is then further transformed 













enzymes. PLP is also required for the conversion of tryptophan to niacin (Leklem et 
al., 1975) and used to produce physiologically active amines includes: histamine from 
histidin, serotonin from tryptophan, -aminobutyric acid (GABA) from glutamate and 
dopamine from dihydroxyphenylalanine (Lee et al., 1988; Schaeffer et al., 1998 and 
references therein). 
PLP is also participated in gluconeogenesis and lipid metabolism. In 
gluconeogenesis, PLP is a required cofactor of glycogen phosphorylase, which is 
necessary for starting gluconeogenesis (Helmreich, 1992). In lipid metabolism, PLP is 
a crucial role of the biosynthesis of sphingolipids, particularly the synthesis of 
ceramide. In this reaction, serine is decarboxylated and combined with palmitoyl-CoA 
to form sphinganine which is combined with a fatty acyl-CoA to form 
dihydroceramide, which is then further desaturated to form ceramide.  
3.2. Vitamin B6 Biosynthesis 
The biochemistry of de novo PLP biosynthesis has been studied in the gram-
negative model organism Escherichia coli (Hill and Spenser, 1996). Also, molecular 
cloning and characterization of genes coding for enzymes involved in PLP 
biosynthesis was performed using this organism, mainly by Malcolm E. Winkler and 
coworkers: The PLP precursor pyridoxine 5'-phosphate (PNP) is synthesized by the 
PdxA and PdxJ enzymes using 4-phosphohydroxy-L-threonine (4PHT; synonym: 3-
hydroxyhomoserine) and 1-deoxy-D-xylulose 5-phosphate (DXP) as substrates (Cane 
et al., 1998; Laber et al, 1999). PNP is oxidized to the active coenzyme PLP by the 
action of PdxH oxidase, a flavoprotein (Lam and Winkler, 1992; Notheis et al., 1995). 
The two substrates DXP and 4PHT are supplied by two independent pathways (Figure 
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1.19), which are both linked to carbohydrate metabolism, or glycolysis and the 
pentose phosphate cyle. DXP is also a precursor in isoprenoid and thiamine (vitamin 
B1) biosynthesis (Begley et al., 1999), and synthesized by the transketolase-like 
enzyme DXP-synthase (DXS) (Lois et al., 1998) using pyruvate and D-
glyceraldehyde-3-phosphate as substrates. 4PHT (Zhao and Winkler, 1996) is formed 
in a series of reactions involving two oxidation steps and one transamination step in a 
pathway similar to serine biosynthesis starting from erythrose-4-phosphate (E4P), a 
central metabolite of the pentose phosphate pathway. E4P is also a precursor of 
aromatic amino acids (L-tryptophan, L-phenylalanine and L-tyrosine) and aromatic 
vitamins (p-aminobenzoate, p-hydroxybenzoate, 2,3-dihydroxybezoate) and it is 
produced directly by the action of transketolases TktA and TktB (Zhao and Winkler, 
1994). These enzymes use D-glycerinaldehyde-3-phosphate and D-fructose-6-
phosphate as substrates to produce Dxylulose-5-phosphate and E4P. In the first 
oxidation step, E4P is converted to 4-phosphoerythronate (4PE) by the action of 
dehydrogenases GapA or Epd (GapB) (Yang et al., 1998). 4PE is further oxidized by 
the PdxB dehydrogenase to 3-hydroxy-4-phosphohydroxy-a-ketobutyrate. By a 
transamination reaction using glutamate as donor, this compound is finally 
transformed into 4PHT by the action of the PdxF (SerC) transaminase, a pyridoxal 5'-
phosphate containing enzyme (Drewke et al., 1996). 
PLP can be synthesized by a salvage pathway (Figure 1.19) that uses B6-
vitamers pyridoxal (PL), pyridoxine (PN) and pyridoxamine (PM) present in the 
growth medium (Hill and Spenser, 1996; Yang et al., 1996). In this pathway, the 
substrates PL, PN and PM are phosphorylated by kinases to form PLP, PNP and 
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substrate specifity have been identified in E. coli: The PN/PL/PM kinase PdxK (Yang 
et al., 1996) and the PL kinase PdxY (Yang et al., 1998a) PNP and PMP are oxidized 
to PLP by the PdxH oxidase which functions in both pathways. Alternatively, PMP 
can be converted to PLP by the action of transaminases. Although PdxA and PdxJ 
have not been found in animals (Ehrenshaft et al. 1999), similar salvage pathways 
involving oxidases and kinases exist in mammalian cells (McCormick and Chen, 
1999). Therefore, species that synthesize PLP have one of the two PLP biosynthetic 
pathways. PLP Homoeostasis is maintaned by relatively unspecific PLP phosphatases. 
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4.  MICRORNA BIOLOGY 
MicroRNAs (miRNA) are small, evolutionarily conserved, non-coding 
ribonucleic acid (RNA) molecules involved in regulation of gene expression in 
essentially all eukaryotic organisms. They are on average 22 nucleotides in length, 
ranging from 18-25 nucleotides (Bartel et al., 2004). MicroRNAs are first described in 
1993 with the identification of lin-4, a small RNA that repressed expression of Lin-14 
protein in the nematode C. elegans (Lee et al., 1993). Presently, there are 1,049 human 
miRNA sequences registered in the miRBase (ver 16.0) miRNA database (Griffiths-
Jones et al., 2008). It is estimated that up to 30% of human genes are regulated by 
miRNA expression (Rajewsky et al., 2004). MicroRNAs are involved in control of 
crucial cellular functions, including proliferation, apoptosis, development, 
differentiation and metabolism (Garzon et al., 2006; Alvarez-Garcia et al., 2005; 
Croce et al., 2005). They are tightly regulated and have been observed to show tissue-
specific expression patterns during embryogenesis (Dalmay, 2008), though they are 
expressed in all tissues and at all stages of development (Hudder et al., 2008) 
4.1. Biogenesis of microRNA 
There are several steps involved in biogenesis of miRNA (Figure 1.20). The 
primary transcript, called pri-miRNA, is typically 3 to 4 kilobases in length with a 5’-
7-methylguanosine (m7G) cap and 3’-polyadenylated [poly(A)] tail, similar to mRNA 
(Lee et al., 2004; Cai et al., 2004; Bracht et al., 2004). Following transcription, a 
stable hairpin structure of at least 30 bp is necessary to serve as the initiation signal for 
the processing steps (Lau et al., 2009). The pri-miRNAs are cleaved in the nucleus by 
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a multiprotein complex called Microprocessor, composed of the RNase III enzyme 
Drosha and double-stranded RNAbinding domain (dsRBD) protein DGCR8/Pasha, to 
produce one or more precursor miRNAs (pre-miRNA) (Lee et al., 2003; Hutvagner et 
al., 2001; Ketting et al., 2001). DGCR8/Pasha recognizes the junction of single and 
double-stranded RNA at the base of the pri-miRNA hairpin, binding Microprocessor 
to it, allowing Drosha to cleave it (Lau et al., 2009). Pri-miRNAs often contain several 
pre-miRNAs, known as clusters. Microprocessor activity can be inhibited through 
direct competitive binding of RNA-binding nuclear proteins (Lau et al., 2009; Ivan et 
al., 2008), structural alterations of pri-miRNA (Guil et al., 2007) or direct protein 
interaction with Microprocessor (Lau et al., 2009).  
Pre-miRNAs are 65-100 nucleotides long with a hairpin structure containing 
a doublestranded RNA stem (Lau et al., 2009). Exportin 5 (Exp5) recognizes the 3’ 
overhang, which is characteristic of pre-miRNA, and a portion of the RNA duplex 
structure (Thomson et al., 2006; Karube et al., 2005) and transports the pre-miRNA 
from the nucleus to the cytoplasm. Once in the cytoplasm, the pre-miRNA is bound by 
a protein complex called RISC-loading complex (RLC), which consists of another 
RNase III, called Dicer, along with Argonaut 2 and TRBP proteins (Gregory et al., 
2005). Dicer recognizes the stem of the hairpin structure as double-stranded RNA and 
cleaves it on the loop side, leaving an 18-25 base pair miRNA duplex (miRNA: 
miRNA*) (Dalmay, 2008; Garzon et al., 2006).  
The strand of the duplex with its 5’ end on the less thermodynamically stable 
end of the duplex, termed the guide strand, is retained and becomes the mature 
miRNA (Chen et al., 2008; Mishra et al., 2008). The other strand, denoted as miRNA*, 
is removed and degraded (Dalmay, 2008; Garzon et al., 2006). This is facilitated by 
53
Dicer, which also may help stabilize the miRNA and play a role in mRNA target 
identification (Lee et al., 2004). The mature miRNA is then incorporated into a protein 
complex formed with an Argonaut family (Ago) protein, called RNA Induced 
Silencing Complex (RISC) (Gregory et al., 2005). There are 4 Argonaut proteins 
expressed in humans, of which only Ago 2 possesses endonucleolytic activity (Hudder 
et al., 2008). 
4.2. Functions and regulation of microRNA 
4.2.1. MicroRNA-mediated gene regulation 
The mature miRNA forms a complex with a member of the Argonaut (Ago) 
protein family, termed the RNA-induced silencing complex (RISC), and guides it 
specifically to the target messenger RNA (mRNA) through base pairing interactions 
generally at the 3’ UTR of the target. Nucleotides 2-7 in the 5’ region of the miRNA, 
called the seed region, bind the target mRNA through near-perfect base-pairing (Lewis 
et al., 2005). The remainder of the miRNA binds the target mRNA with varying 
degrees of complementarity (Lewis et al., 2005). If the miRNA is a perfect or 
nearperfect complement, cleavage and degradation of the mRNA is induced through 
de-capping of the 5’ m7G cap or de-adenylation of the poly(A) tail. If there is a partial 
complement, RISC inhibits translation through competitive m7G cap binding by Ago 
2 with the translational initiating factor eIF4E (Kiriakidou et al., 2007). These 
translationally-silenced mRNA:RISC complexes remain in the cytoplasm and 
accumulate, forming processing bodies (P-bodies) (Bhattacharyya et al., 2006). P-
bodies contain decapping proteins and exoribonuclease, and therefore are capable of 
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degrading the mRNAs. However, there is newly emerging evidence that miRNA 
translational silencing may be reversible, allowing mRNAs to leave P-bodies and 
migrate to ribosomes for translation (Bhattacharyya et al., 2006). Since base pairing 
with the target does not have to be a perfect compliment, a single miRNA can 
potentially affect mRNA and protein levels of 200 or more genes (Rouhi et al., 2008). 
4.2.2. Epigenetic regulation of microRNA 
MicroRNA expression can be regulated epigenetically, either through DNA 
methylation (Rouhi et al., 2008) or histone modification (Scott et al., 2006). 
Approximately 10% of miRNAs are regulated by DNA methylation (Han et al., 2007) 
and are more frequently methylated than protein-coding genes (Weber et al., 2007). 
Although it is currently unknown exactly why this is, three general reasons have been 
suggested (Weber et al., 2007); first, the increased frequency of miRNA methylation 
could be due to the specific nucleotide sequences surrounding the miRNA-associated 
CpG islands; second, miRNA could be embedded in specific chromosomal structures 
predisposing them to methylation; third, the predilection for methylation could be 
related to the tight regulation of miRNA expression. 
There are three general mechanisms by which miRNA expression can be 
controlled through methylation: first, most commonly, miRNA can be embedded 
within or near a CpG island, which functions as its promoter (Rouhi et al., 2008); 
second, miRNAs can be located within an imprinted region (Royo et al., 2008; Seitz et 
al, 2004), thus preventing transcription; third, intronic miRNAs can be regulated by 
CpG island methylation of the promoter of the host gene (Grady et al., 2008; Lin et al., 
2006). About forty-seven percent of miRNAs in the miRNA registry database 
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(miRBase), and all miRNAs currently linked to epigenetic regulation, are associated 
with CpG islands (Weber et al., 2007). Some miRNA promoters are unmethylated in 
normal tissue, while others are normally methylated (Rouhi et al., 2008; Brueckner et 
al., 2007). Promoter methylation of miRNA results in reduced expression or 
transcriptional silencing.  
4.3. Promoters and miRNA 
4.3.1. MicroRNA transcription 
As previous mentioned, microRNA expression is regulated by transcription 
factors and transcribed by RNA Polymerase II (Pol II), similar to protein-coding genes, 
although the precise mechanisms of transcriptional control of miRNAs are not entirely 
understood. While most miRNAs reside within intergenic non-coding regions 
(Lujambio et al., 2007), they can also be located in introns, exons or untransclated 
regions (UTRs) of coding genes (Rouhi et al., 2008; see Figure 1.21). Many miRNAs 
are embedded close to other miRNAs in the genome, giving rise to miRNA clusters 
(Lujambio et al., 2007). Single and clustered miRNAs can be transcribed from their 
own promoters, generally located within 500 base pairs of the 5’ end of the miRNA, 
as single or polycistron transcriptional units, respectively (Lujambio et al., 2007; Zhou 
et al., 2007). 
4.3.2. Promoter regions 
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Pol II. While Pol II binds to the DNA at the transcription initiation point, it is not 
capable of directly recognizing its target (Nikolov et al., 1997). A complex of proteins 
in a region known as the core promoter binds to the DNA whereupon they recruit Pol 
II to the transcription start site (TSS). Other proteins, called transcription factors (TFs), 
then bind to the proximal promoter or enhancer regions to either activators or 
repressors the activation of Pol II.  
The core promoter region typically consists of the couple hundred base pairs 
surrounding the TSS of a gene. This region was once thought to contain a handful of 
known features able to be bound by elements of the Pol II protein complex; though it 
is now known that there is a wide diversity of properties that can be identified. It was 
initially believed that the core promoter regions consisted of a TATA box (~30bp 
upstream of the TSS) and an initiator sequence (Inr; overlaps the TSS). Recent studies 
have estimated the prevalence of these two sequences in only about 16% of human 
promoters (Yang et al., 2007), typically for tissue specific genes (Carninci et al., 
2006). It has been identified that approximately half of the human core promoters are 
located around CpG islands. CpG islands are regions of a high concentration of CG 
dinucleotides, which are very underrepresented across the genome (Antequera, 2003).  
For non-CpG island related promoters it was discovered that addition 
sequences such as the down stream promoter element (DPE; ~28bp downstream of the 
TSS) and the TFIIB recognition element (BRE; ~35bp upstream of the TSS) were also 
targets for proteins involved in the recruitment of RNA Pol II to the TSS besides the 
TATA box and the Inr. While some hypothesized that at least 2 of these 5 elements 
were necessary for the transcriptional initiation complex to bind (Gershenzon et al., 
2005), other researchers have identified gene specific elements capable of binding this 
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complex such as the downstream core element (DCE) in the human β-globin promoter 
(Smale and Kadonaga, 2003) and the multiple start site downstream element (MED-1) 
in the pgp1 promoter (Ince et al., 1995). This suggests that the core promoter structure 
may be more complicated than originally hypothesized.  
CpG islands are found at a low frequency in the genome because methylated 
CG dinucleotides can easily be mutated to TG dinucleotides, a process that is not 
corrected by DNA repair mechanisms (Smale and Kadonaga, 2003). Genes that have 
CpG islands in their promoters tend to be ubiquitously expressed across most tissues 
and throughout development. DNA methylation is a mechanism for which the cell can 
block the binding of transcription factors to promoters in order to prevent transcription 
of certain genes; because genes with CpG islands tend to be continuously expressed, 
they have not had as many opportunities to be methylated relative to the remainder of 
the genome (Antequera, 2003). Another feature that distinguishes genes with CpG 
islands is that they are more likely to have multiple TSSs that can span over 100bp 
whereas TATA-Inr containing promoters tend to have just one TSS (Carninci et al., 
2006). The transcription factor Sp1 is capable of binding to CpG islands and recruiting 
Pol II (Lee et al., 2005). 
4.3.3. Transcription factors 
The regulatory regions outside of the core promoter are the proximal 
promoter region and the enhancer regions. These regions, which can be located 
upstream of the gene, downstream of the gene, or even in the gene’s introns, are bound 
by TFs that activate or repress the functionality of Pol II (Ng et al., 1989). TFs will 
typically consist of a DNA binding domain and in the case of activators, an activation 
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domain. Each TF usually binds to a specific set of sequence motifs 6-15bp in length 
(Stormo, 2000). The over 2,000 human TFs can be broken down into families based 
upon their structural properties that will typically correspond to their preferred binding 
motif (Mahony et al., 2007; Sandelin et al., 2004). TFs can function individually, in 
tandem, or in competition with each other (Umetani et al., 2001).  
The identification of transcription factor binding sites (TFBSs) in the genome 
is an important and highly researched subject. The advancement of large-scale 
chromatin immunoprecipitation technology (ChIP-chip) has provided biologists with 
the tools necessary to identify many binding sites for a specific factor (Buck et al., 
2004). The limitations of these studies are that the results only provide information on 
one specific cell type, one cellular condition, and only a single TF. In addition to 
laboratory procedures that can identify TFBSs, computational biologists have taken up 
the task of locating their motifs given the complete sequences of genomes and some 
external information.  
A variety of computational methods have been developed over the years for 
the identification of TFBSs. The short and often degenerate nature of the sequences 
makes them a challenge to identify over large genomic regions (Corcoran et al., 2005). 
Algorithms have been developed that search for specific strings of sequences that 
match known TFBSs, called library based methods. Other methods use an IUPAC 
alphabet in the form of a consensus sequence to match the variability in TFBSs 
(Quandt et al., 1995). The most common method of representing the binding motifs of 
a TF is a position-specific scoring matrix (PSSM). A PSSM provides a mathematical 
model that represents all of the known binding sites for a given TF (Stromo et al., 
2000). The PSSM can be combined with other features to help in the efficiency of 
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identifying TFBSs such as sequence conservation across species or looking for 
common TFBSs in the promoters of genes that appear to be co-regulated given the 
similarity in their expression profiles (Corcoran et al., 2005; Bussemaker et al., 2001; 
Lenhard et al., 2003; Loots et al., 2004; Roth et al., 1998).  
The identfication of TFBSs is an essential step in the understanding of gene 
regulatory networks. The further analysis of miRNA promoters and the transcription 
factors that bind them will be an essential component to the understanding of the 
regulatory networks in hich they participate. 
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5.  EPIGENETICS 
Epigenetics is defined as heritable but reversible changes in gene expression 
due to genetic modifications without a change in the DNA sequence (Esteller et al., 
2008; Jiang et al., 2004; Liard., 1996). These changes include DNA methylation and 
histone modifications, and play crucial roles in various biological processes such as 
the regulation of gene expression, embryonic development and genomic stability 
5.1. DNA methylation 
DNA methylation occurs at dinucleotides in which cytosine is upstream and 
adjacent to guanine, called CpGs. This takes place when S-adenosylmethionine (SAM) 
donates a methyl (CH3) group that is covalently attached to the 5-carbon of a cytosine 
pyrimidine ring in a reaction catalyzed by the enzyme DNA methyltransferase 
(DNMT) (Zangi et al., 2010). Approximately 50-70% of CpG dinucleotides are 
methylated in normal human tissue, termed global methylation (Ehrlich et al., 1982). 
However, most of the human genome is depleted of CpG dinucleotides due to the 
relative instability of m5C, which can result in spontaneous hydrolytic deamination of 
the cytosine base to thymine (Gronbaek et al., 2007). CpGs are not randomly 
distributed throughout the genome but rather are concentrated in CpG enriched 
regions (Esteller et al., 2008; Gronbaek et al., 2007; Shi et al., 2007) referred to as 
CpG islands. Specifically, CpG islands are defined as a sequence greater than 0.5 kb 
with a G+C content greater than or equal to 55% and an observed vs. expected CpG 
ratio greater than 60% (Takai et al., 2002). They typically range from 0.5 to 5 kb in 
length and occur on average every 100 kb in the genome (Das et al., 2004). These 
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CpG islands are often disproportionately concentrated in the 5’ promoter regions of 
genes. Approximately 50% of all human genes have CpG islands in the promoter 
region. While CpG dinucleotides are frequently methylated in normal tissue, 
promoter-associated CpG islands are generally not methylated, although methylation 
of subgroups of CpG islands may occur (Gronbaek et al., 2007; Shi et al., 2007). 
During DNA replication, the methylation pattern of the parent strand is 
transferred onto the new strand by DNMT1 (Zangi et al., 2010). DNMT1 has an 
affinity for hemimethylated DNA (Bestor et al., 1992). However, during early 
embryonic development or carcinogenesis, previously unmethylated DNA may be 
methylated in a process mediated by DNMT3a or DNMT3b, which is termed de novo 
methylation (Gronbaek et al., 2007; Das et al., 2004). DNMT3b has a propensity to 
target pericentromeric satellite regions for methylation, which are prone to loss of 
stability as a result of hypomethylation, leading to chromosomal breakage (Okano et 
al., 1999). 
There are several mechanisms guarding against aberrant promoter 
methylation (hypermethylation), including active transcription, active demethylation, 
timing of replication and prevention of access to DNMT by local chromatin structure 
(Das et al., 2004). Enzymes that actively demethylate DNA are called demethylases. 
These may include the glycosylases thymine-DNA glycosylase (TDG) and methyl-
CpG-binding domain protein 4 (MBD4), which remove the methylated cytosine (5-
meC) leaving the deoxyribose intact to be replaced with a new cytosine via DNA 
repair (Gehring et al., 2009; Zhu et al., 2009); methyl-CpG-binding protein 2 (MBD2), 
which is believed to demethylate by hydrolyzing 5-meC to cytosine and methanol 
(Das et al., 2004); or thymine removal by glycosylases through the G/T mismatch 
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base excision repair pathway following 5-meC deamination to thymine by DNMT3a 
or DNMT3b (Zhu et al., 2009). 
Generally, methylation of CpG islands in the promoter region is associated 
with transcriptional silencing of the gene, whereas methylation of downstream gene 
sequences has no influence on expression (Gronbaek et al., 2007; Figure 1.22). DNA 
methylation is capable of repressing gene expression in three general ways. One 
mechanism is through direct interference with transcription factors. Several 
transcription factors, including AP-2, c-Myc, CREB, E2F, and NFkB, recognize and 
bind promoter regions containing CpG islands and are inhibited by methylation. A 
second mechanism involves inhibition of transcription through the direct binding of 
transcriptional repressors to 5-meC in the promoter region, including MBD1, MBD2, 
MBD4, Kaiso, MeCP1, and MeCP2. Finally, CpG methylation can guide the 
deacetylation of histones and subsequently alter chromosome structure to prevent 
transcription. Methylated cytosines of silenced promoters can bind methyl-CpG-
binding-domain proteins (MBD), forming a complex involving histone deacetylase 
enzymes (HDAC) (Gronbaek et al., 2007; Das et al., 2004). 
5.2. Histone modification 
Promoter methylation is not the sole epigenetic mechanism capable of 
silencing gene expression. Modification of histone proteins can result in the alteration 
of chromatin structure, directly affecting gene transcription, DNA repair, DNA 
replication and chromosomal organization (Esteller et al., 2008; Carley et al., 2007; 
Gronbaek et al., 2007). Histones are protein octamers, containing 2 of each of H2A, 
H2B, H3, and H4, around which approximately 146 bp of DNA is wound, forming a 
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for gene expressions.
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nucleosome. The nucleosome is a recurring structure of eukaryotic DNA that 
comprises the chromosomes, condensing the DNA so that the entire genome can fit 
into the nucleus. Most chromatin exists as tightly compacted nucleosomes, called 
heterochromatin, which is transcriptionally incompetent. This is represented by the 
dark staining portion of the nucleus on light microscopy. Euchromatin has less 
compact nucleosomes, forming an open chromatin structure that can be readily 
transcribed. This appears as the lightly staining portion of the nucleus on light 
microscopy (Gronbaek et al., 2007). 
Histone modification occurs in different histone proteins, histone variants 
and histone residues such as lysine, arginine and serine. Modifications typically 
involve addition or removal of acetyl or methyl groups to the histone proteins at the 
N-terminal tails protruding from the nucleosomes (Zangi et al., 2010; Esteller et al., 
2008; Gronbaek et al., 2007).  
Histone acetylation is associated with transcriptional activation (Figure 1.22). 
In transcriptionally active promoters with unmethylated cytosines, histones are 
acetylated by histone acetyl transferases (HAT). These form a complex with 
transcription activator and coactivator proteins to initiate transcription. Conversely, 
histone deacetylases (HDAC) form complexes with methyl-CpG-binding-proteins 
(MBD) and methylated cytosines in the promoter, allowing them to remove acetyl 
groups from the N-terminal tails of the histones, causing condensation of the 
nucleosome, resulting in transcriptional inactivation (Esteller et al., 2008; Gronbaek et 
al., 2007). 
Histone methylation can result in either transcriptional activation or 
repression, depending upon the protein and amino acid type methylated and its 
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position in the histone tail (Esteller et al., 2008; Gronbaek et al., 2007). It can also 
have different degrees, including mono-, di- and trimethylation. Histone methylation 
is catalyzed by a class of enzymes called histone methyltransferases, while histone 
demethylases are responsible for demethylation (Bartova et al., 2008). Trimethylation 
of lysine at position 9, 27, or 36 of the N-terminal tail of H3 (H3K9, H3K27, or 
H3K36) or lysine at position 20 on H4 (H4K20) results in chromosomal structure 
alterations (heterochromatin) leading to transcriptional silencing (Bracken et al., 2006; 
Kahlil et al., 2009). Trimethylation of lysine at position 4, 36, or 79 on H3 (H3K4, 
H3K36 or H3K79) is associated with a euchromatin conformation and active 
transcription (Okitsu et al., 2010; Bartova et al., 2008; Lachner et al., 2001; Santos-
Rosa et al., 2002). Several other covalent methyl histone modifications have been 













SYNTHETASE 1 REGULATES  
VITAMIN B6 METABOLISM:  




1.  INTRODUCTION 
Selenium has been reported to provide many health benefits in animals, 
including humans, when obtained from the diet in adequate amounts. For example, 
selenium has been known to play roles in cancer prevention, aging retardation, 
immune augmentation, prevention of heart diseases, muscle development and 
development (Boosalis et al., 2008; Flohé et al., 2007; Hatfield et al., 2006; Tamura et 
al., 2004 and references therein; see Figure 1.9). Many of the health benefits of 
selenium are mediated by selenoproteins, which contain selenocysteine (Sec) as a 
selenium containing amino acid (Hatfield et al., 2006).  
Selenophosphate synthetase (SPS) synthesizes selenophosphate (SeP), the 
active selenium donor in Sec biosynthesis, using selenide and ATP as substrates 
(Ehrenreich et al., 1992; see Figure 1.13). SeP serves as a selenium donor during Sec 
biosynthesis (Glass et al., 1993). Sec is contained in all selenoproteins (Aitken et al., 
2005). SPS was first isolated from Escherichia coli as one of the enzymes involved in 
selenoprotein synthesis and was designated SelD (Leinfelder et al., 1990). Only one 
type of SPS, SelD, exists in lower eukaryotes and eubacteria, however, there are two 
isoforms of SPS, SPS1 and SPS2, occur in higher eukaryotes (Guimaraes et al., 1996). 
One of the major differences in the sequences between SPS1 and SPS2 is that SPS1 
has an arginine at the position corresponding to Sec in SPS2 (Low et al., 1995).  
Although it is not clear why there are two SPSs in higher eukaryotes, recent 
studies have shown that SPS2 synthesizes SeP from selenide and ATP in vitro, while 
SPS1 does not have this activity (Xu et al., 2007). Loss of function in NIH3T3 cells 
using RNA interference technology showed that SPS2 is required for selenoprotein 
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biosynthesis, while SPS1 does not affect the biosynthesis of this protein class (Xu et 
al., 2007). While some insects such as the red beetle and silkworm have lost the 
selenoprotein synthesizing machinery including SPS2, SPS1 is still encoded in the 
genome of these insects, suggesting SPS1 is required for a function other than SeP 
synthesis (Lobanov et al., 2008).  
Although SPS1 does not catalyze SeP biosynthesis, it plays essential roles in 
the cell. When the gene encoding SPS1 (SPS1, also designated patufet) was deleted in 
Drosophila, the embryo showed lethality during development (Alsina et al., 1998), 
and reactive oxygen species (ROS) levels increased (Morey et al., 2003). The 
haploinsufficiency of genes involved in the Ras-regulated signaling pathway was also 
suppressed by SPS1 knockout in Drosophila (Morey et al., 2001). From the finding 
that the SelD (E. coli SPS) mutant of E. coli can be complemented by human SPS1 
only when L-Sec is supplemented in the medium, it was suggested that SPS1 is 
involved in the recycling of Sec (Tamura et al., 2004). However, the means by which 
SPS1 may be involved in Sec recycling has not been determined. Recently, it was 
found that the targeted depletion of SPS1 by RNA interference in Drosophila SL2 
cells causes growth inhibition, ROS induction and megamitochondrial formation by 
increasing intracellular glutamine levels (Shim et al., 2009). Interestingly, human 
SPS1 was found to interact with the soluble liver antigen, which was recently 
identified as eukaryotic Sec synthase (SecS), and the binding reaction was enhanced 
by Sec tRNA methylase designated SECp43 (Small-Howard et al., 2006; Xu et al., 
2007). It should be noted that SecS is a pyridoxal phosphate (PLP)-dependent enzyme 
and, therefore, the uptake and/or activation of vitamin B6 may be related to selenium 
metabolism (Forchhammer et al., 1991; Ganichkin et al., 2008).  
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Vitamin B6 is a water-soluble compound that contains a pyridine ring and is 
part of the vitamin B complex group (Combs, 2008). Vitamin B6 is present in nature as 
several different forms such as pyridoxal (PL), pyridoxine (PN), pyridoxamine (PM) 
and their 5’-phosphorylated forms, including pyridoxine 5’-phosphate (PNP), 
pyridoxal 5’-phosphate (PLP), and pyridoxamine 5’-phosphate (PMP) (Fitzpatrick et 
al., 2007; see Figure 1.18). Before use, these vitamers are converted to PLP, which is 
the metabolically active form. PLP is used as a cofactor for PLP-dependent enzymes, 
where the pyridine ring acts as an electron sink during enzymatic reactions. PLP is 
involved in the variety of macronutrient metabolism, including neurotransmitter, 
histamine and hemoglobin synthesis and can help facilitate decarboxylation, 
transamination, racemization, and replacement and –group interconversion reactions 
(Grogan, 1988; Mihara et al., 1997). Since animals, including humans, cannot 
synthesize vitamin B6, they must obtain it from their diet (Mooney et al., 2009). PLP 
can be synthesized through several different pathways, and two types of enzymes, 
kinases and oxidases, participate in these pathways. For PM to be converted to PLP, it 
is first phosphorylated by a kinase (PL/PM/PN kinase) to form pyridoxamine 
phosphate (PMP), and then the PMP is oxidized to form PLP using an oxidase 
(PMP/PNP oxidase). PN can also be converted to PLP using the same kinase and 
oxidase used for PM. In this case, the phosphorylated intermediate is pyridoxine 
phosphate (PNP). However, PL can be directly converted to PLP by phosphorylation 
using a kinase (Gonza´lez et al., 2007). Therefore, kinases and oxidases are important 
enzymes for PLP synthesis. 
There are more than 100 PLP-dependent enzymes in a cell that perform 
essential roles in various metabolic pathways including amino acid metabolism (such 
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as amino acid synthesis and degradation), fatty acid metabolism (such as the synthesis 
of polyunsaturated fatty acids), and carbohydrate metabolism (such as the breakdown 
of glycogen) (Mooney et al., 2009 and references therein). The PLP-dependent 
enzymes that participate in amino acid metabolism can be classified into 4 categories: 
transaminase, racemase, decarboxylase and α, β-eliminase (Yoshimura et al., 2008). 
Interestingly, the biosynthesis of Sec can be mediated by cystathionine β-synthase 
(CBS) using serine as a precursor and it can also be synthesized by cystathionine ɣ-
lyase (CGL) from selenocystathionine (Esaki et al., 1981; Meier et al., 2001). Both 
CBS and CGL are PLP-dependent enzymes (Aitken et al., 2005). In addition, enzymes 
that are involved in the degradation of Sec, such as selenocysteine lyase (SCL), D-
selenocystine α, and β-lyase, use PLP as a cofactor (Soda et al., 1998). Recently, it 
was found that SCL can interact with SPS1 (Tobe et al., 2009). Therefore, it seems 
that vitamin B6 participates in the metabolism of Sec, i.e., in the biosynthesis and/or 
decomposition of Sec.  
In the present study, we found that the knockdown of SPS1 led to the down 
regulation of genes involved in PLP biosynthesis, which, in turn, induced the 
formation of megamitochondria and the expression of genes responsible for innate 
immunity. Our findings suggest that SPS1 primarily regulates PLP biosynthesis, and 
the intracellular PLP level affects various biological processes such as amino acid 
metabolism, megamitochondrial formation and innate immune response. 
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2.  MATERIALS AND METHODS 
2.1. Reagents and other materials 
Materials were purchased from the following sources: Drosophila Schneider 
cell line 2 (SL2) was purchased from Invitrogen, HyQ SFX-Insect medium from 
Hyclone, T3 Megascript kit from Ambion, RNeasy mini kit from Qiagen, GeneChip 
Drosophila genome 2.0 array from Affymetrix, SYBR Green mix from Applied 
Biosystems, TRIzol reagent from Invitrogen, Moloney murine leukemia virus reverse 
transcriptase from Super-Bio, 4-deoxypyridoxine hydrochloride from TCI, 5’,6,6’-
tetrachloro-1,1’,3,3’-tetraethylbenzimidazolyl-carbocyanine iodide (JC-1) from 
Molecular Probes, and oligonucleotides from Cosmo Genetech. The sequences of 
oligos used for RT-PCR are listed in Table 2.1. 
2.2. SL2 cell culture and RNA interference 
SL2 cell culture and preparation of double-stranded RNAs were carried out 
as described (Shim et al., 2009). Briefly, for RNA interference, 0.25×106 cells were 
plated on a 24-well plate containing 0.5 ml of HyQ SFX-Insect medium. Four 
micrograms of dsRNAs were added directly to the medium and incubated for 48 hr 
and cells were split into appropriate culture dishes for further incubation and other 
experiments. 
2.3. Microarray experiment 
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Cec B aatccgatcgtaagccaaca Agagaaatgagcgggtcgag
Drs gtacttgttcgccctcttcg acaggtctcgttgtcccaga
Dro cataccgcggagaagtcatc ttaggggacaaacccattca










RP49 cagtcggatcgatatgcta aatctccttgcgcttctt 
Table 2.1. Oligonucleotides sequences used as primers for RT-PCR or real-time PCR
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Microarray experiments were performed using the GeneChip Drosophila 
genome 2.0 array. After the addition of double stranded RNAs targeting SPS1 to the 
culture medium, total RNA was extracted from SL2 cells treated with or without SPS1 
dsRNA on day 1, 3 and 5 after treatment using the RNeasy mini kit according to the 
manufacturer’s instructions. The cells that were not treated with any dsRNA were used 
as controls. The RNA quality was checked using Experion (Applied Biosystems) 
according to the manufacturer’s instructions. Five micrograms of total RNAs were 
reverse transcribed with oligo-dT primer containing a T7 RNA polymerase promoter 
(TAATACGACTCACTATAGGG). Biotin-labeled cRNAs were generated from the 
cDNA sample by in vitro transcription with T7 RNA polymerase. The labeled cRNAs 
were fragmented to an average size of 35-200 bases by mild alkaline treatment at 94°C 
for 40 min. Fragmented cRNAs were hybridized with probes that are on GeneChip 
Drosophila genome 2.0 array, and the chips were washed and stained in the 
Affymetrix Fluidics Station 450 by following the procedures established by 
Affymetrix (Affymetrix GeneChip R Expression Analysis Technical Manual). The 
signals were scanned using the GeneChip Scanner 3000 7G (Affymetrix). Overall 
experimental scheme of microarray is shown in Figure 2.1. 
2.4. Microarray data processing 
The raw data were imported into Acuity 4.0 software (Molecular Devices, 
Inc.), and a background adjustment and normalization were performed using robust 
multichip average (RMA) and quantile methods, respectively, implemented in Acuity 
4.0 software (Bolstad et al., 2003; Irizarry et al., 2003). To identify differentially 
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and fitted using the R software (www.r-project. org), as described by Park et al (Park 
et al., 2003). Two models were considered to identify DEGs. Model 1 contains group 
and time effects as well as their interactions. Model 1 allows the expression level of 
genes to change over time (days 1, 3 and 5) and these change patterns to differ 
between groups (control and knockdown). Model 2 includes only group and time 
effects assuming that the expression level of genes changes over time but these change 
patterns are the same between groups. From Model 1, DEGs were identified by the 
genes with significant interaction effects, while from Model 2 DEGs were identified 
by the genes with significant group effects. The p-values were adjusted by Westfall 
and Young’s method (Westfall et al., 1993). The genes with adjusted p-values less than 
0.1 were identified. 
2.5. Temporal clustering  
To classify DEGs according to their temporal expression pattern, DEGs were 
clustered using a self-organizing map (SOM) algorithm implemented in Acuity 4.0 
(Tamayo et al., 1999). The ratios of normalized log2 values of DEGs between SPS1 
knockdown cells and control cells were used as input data and the SOM map size was 
set to 3ⅹ2. The ranges of expression ratios of DEGs within each cluster at each 
sampling date were displayed by box plot using R software. The interquartile ranges 
(IQRs) of each cluster were compared to select cluster(s) whose IQRs were 
significantly deviated. The criterion for determining clusters within which gene 
expressions were changed significantly was set to 0.75, i.e., when the interquartile 
range (IQR) of a cluster was larger than +0.75 or smaller than −0.75, the cluster was 
selected as significantly changed. This is because 0.75 is the threshold value to isolate 
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clusters on day 3 (see Results for more details). The genes composing a cluster 
selected at the early stage (day 3) were defined as an early responding gene-set and 
those composing a cluster selected at the late stage (day 5) were defined as a late 
responding gene-set.  
2.6. Gene ontology analysis 
GO analysis was performed by BiNGO version 2.3 (Maere et al., 2005), 
which is plugged in Cytoscape (Shannon et al., 2003). Gene symbols of each gene-set 
were used as input data. The parameters were set as follows: assessment was set to 
overrepresentation, statistical test to binomial test, multiple testing correction to 
FWER correction, significance level to 0.05. Among GO evidence codes, inferred 
from electronically annotated (IEA) were discarded. The most significant pathway was 
predicted by considering the selected GO terms and visualized output.  
2.7. RT-PCR and quantitative real time RT-PCR 
RT- PCR and real time PCR were carried out as described (Shim et al., 2009). 
Briefly, total RNA was isolated from the cells using the TRIzol reagent. cDNAs were 
synthesized from total RNAs with Moloney murine leukemia virus reverse 
transcriptase and oligo (dT) primers according to the manufacturer’s protocols. RT-
PCR was performed with 0.1 μg of template total RNA and specific primers (Table 
2.1). RT-PCR products were electrophoresed on a 2 % agarose gel and visualized by 
ethidium bromide. For the measurement of relative mRNA levels of each gene, real 
time PCR was carried out using an ABI 7300 real time PCR system (Applied 
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Biosystems) as follows. cDNAs were amplified using SYBR Green mix and specific 
primers for 40 cycles [initial incubation at 50°C for 2 min and then at 95°C for 10 min, 
and 40 cycles (95°C for 15 sec, 55°C for 1 min and 72°C for 1 min)]. Output data 
were obtained as Ct values using Sequence Detection Software (SDS) version 1.3 
(7300 System, Applied Biosystems) and the differential mRNA expression of each 
gene between control and knockdown cell was calculated using the comparative Ct 
method (Schmittgen et al., 2008). RP49 mRNA, an internal control, was amplified 
along with the target genes, and the Ct value of RP49 used to normalize the expression 
of target genes. 
2.8. Measurement of intracellular PLP concentration 
Cellular PLP levels were determined using the method previously described 
(Perry et al., 2007) with minor modifications. At day 5 after treatment with dsRNA or 
4-DPN, cells were washed with phosphate buffered saline and harvested. Cells (6× 107) 
were lysed by resuspension in 600 l of distilled water. Cell extracts were induced to 
produce the semicarbazon derivative of PLP as follows: 40 l of 250 mg/ml of both 
semicarbazide and glycine were added into 500 l of cell extracts or PLP standard. 
The mixture was vortexed and incubated at room temperature in the dark for 30 min. 
Proteins were then precipitated by adding 50 μl of 60% HClO4 into the mixture, and 
the solution was thoroughly mixed for 1 min. The solution was clarified by 
centrifugation for 10 min at 15,000×g, and 30-50 l of a 25% NaOH solution was 
added to the supernatant to achieve a pH between 3.0 and 5.0. HPLC was performed 
using a ZORBAX SB-C18 column (4.6 mm × 25 cm, PN 880975902) and an isocratic 
mobile phase consisting of 60 mM sodium phosphate (pH 6.5), 400 mg/l EDTA and 
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9.5% methanol at a flow-rate of 1 ml/min, and the derivatized PLP was quantified 
using a WatersTM 474 scanning fluorescence detector by setting excitation and 
emission wavelengths to 380 and 450 nm, respectively. 
2.9. Mitochondrial staining and confocal microscopy 
Mitochondrial staining and confocal microscopy were carried out as 
described (Shim et al., 2009). Briefly, SL2 cells (0.5×106) were plated onto a 
chambered coverglass one day before staining. Cells were incubated with 1 μg/ml JC-
1 for 30 min at 25 °C, washed three times with HyQ-SFX-Insect medium and 
observed with a LSM510 confocal microscope (Carl Zeiss) at 512×512 pixel 
resolution through an X63 C-Apochromat objective. Excitation wavelengths for JC-1 
aggregate and JC-1 monomer were 543 and 488 nm, respectively. 
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3.  RESULTS 
3.1. Identification of differentially expressed genes 
To elucidate the molecular function of SPS1, DEGs were identified by 
microarray analysis in SL2 cells where Drosophila SPS1 was knocked-down. After 
the addition of double stranded RNAs targeting SPS1 to the culture medium, total 
RNAs were isolated on days 1, 3 and 5 after treatment and subjected to microarray 
analysis using Affymetrix microchips (GEO accession number: GSE 17685).  
Because megamitochondrial formation begins 3 days after knockdown (Shim et al., 
2009), transcriptomes were analyzed before and after megamitochondrial formation to 
find the primary target of SPS1. The knockdown efficiency was approximately 90% 
which was similar with that obtained in the previous work (Shim et al., 2009). The 
log2 values of signal intensity of 18,952 transcripts on each chip were obtained after 
normalization. By performing two-way ANOVA analysis (adjusted P-value < 0.1) 
against the log2 values of signal intensities of transcripts, a total of 238 genes were 
found to be different in their expression between knockdown and control cells. 
Twenty-three genes were selected by model 1 and 227 genes by model 2, with 12 
genes being common between the two models (Figure 2.2). Among these genes, only 
one gene (SPS1) showed more than two-fold change in expression on day 1. However, 
55 and 201 genes among DEGs were found to have more than two fold expression 
changes on day 3 and 5, respectively. These results suggest that the effect of SPS1 
knockdown on the expression of target genes were manifested slowly. List of DEGs 
was shown in Table 2.2. 
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Figure 2.2. Identification of DEG
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3.2. Functional distribution of differentially expressed genes  
 Total 238 identified DEGs were classified according to their GO terms, 
especially biological process and molecular function terms. One hundred and forty-
eight genes (61.9%) could be annotated with their GO terms by direct searching GO 
database. As shown in Figure 2.3, the annotated functions of DEGs were classified 
into 9 categories. Genes participating in primary metabolic process, including 
carbohydrate, amino acid and protein metabolic process, took the largest portion 
among the genes whose functions were annotated (31.16%). The portion of genes 
participating in developmental process, transport and defense response were 17.6%, 
14.9% and 12.8%, respectively. Therefore, the number of genes fallen into those four 
GO categories were more than 70% among the annotated genes suggesting SPS1 
participates majorly in metabolic process, development, cell transport and defense 
response. Minor portion of DEGs was taken by the genes participating in signaling 
(5.4%), oxidation/reduction (5.4%), cellular component organization (4.7%), response 
to stimulus (4.1%) and gene expression (4.1%). It should be noted that the major effect 
of SPS1 knockdown was megamitochondrial formation mediated by the accumulation 
of glutamine and growth inhibition (Shim and Kim et al., 2009). Therefore, it is 
interesting that genes related with the metabolic process were the most abundant 
among DEGs. The DEGs related with development can also participate in cell growth. 
It is, however, uncertain that defense response is related with megamitochondrial 
formation and cell growth. Cell growth inhibition and activation of cell defense 
system by SPS1 knockdown seems to be resulted by the secondary effect after 
knockdown, because those effects were shown at relatively late stage (approximately 4 
days after knockdown) and were very wide. Therefore, it is necessary to identify the 
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Figure 2.3. Pie chart representing
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primary effect by analyzing the DEGs detected at early stage. To identify the primary 
effect of SPS1 knockdown, temporal clustering and GO analysis were performed. 
3.3. Construction of gene sets by temporal clustering  
3.3.1. Clustering DEGs by SOM algorithm 
To analyze the expression pattern of DEGs generated by SPS1 knockdown, 
clustering of DEGs was performed according to their temporal expression using by 
self-organizing map (SOM) algorithms (Tamayo et al., 1999). As a result, the DEGs 
were classified into 6 clusters (Figure 2.4). Genes belonging to cluster 1 (33 genes) 
showed continuous increase in their expression by SPS1 knockdown, and most of 
them showed more than 4-fold increase on day 5. The expression patterns of genes in 
cluster 2 (77 genes) were similar to those of cluster 1, but the average expression level 
was lower than that of cluster 1. Genes in cluster 3 (9 genes) showed down-up patterns 
of expression. The expression of cluster 4 genes (12 genes) was decreased until day 3, 
and the expression level was maintained afterward. The expression pattern of genes in 
cluster 5 (27 genes) was a down-down type. Genes in cluster 6 (80 genes) showed an 
expression pattern similar to that of cluster 5 genes. However, the average level of 
expression of cluster 5 genes was much lower than that of cluster 6 genes.  
3.3.2. Functional distribution of six clusters 
We further examined how genes within each functional category distributed 
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evenly distributed in all clusters, although the relative percentages are slightly 
different suggesting various genes were regulated in various ways. However, most of 
genes involved in development were distributed in cluster 2 and 6 suggesting these 
genes were either slightly up-regulated or slightly down-regulated. Majority of genes 
responsible for transport, oxidation/reduction, signaling, and response to stimulus are 
found in cluster 2 suggesting they were slightly up-regulated. Most of genes 
responsible for cellular component organization and gene expression are fallen into 
cluster 6 suggesting these gene were slightly down-regulated. Genes responsible for 
defense response are equally distributed in both cluster 1 and 2 suggesting these genes 
were up-regulated. 
3.3.3. Construction of three gene sets for GO analysis 
Using six clusters resulted from SOM clustering, the expression ratios of 
DEGs composing a cluster were drawn as a box plot according to their sampling date 
(days 1, 3, and 5). As shown in Figure 2.6, the median values (Q2s) of all clusters 
were close to zero on day 1. However, Q2s of clusters 3, 4 and 5 on day 3 were 
significantly decreased. On day 5, Q2s of clusters 1 and 2 were significantly increased, 
while those of clusters 4, 5 and 6 decreased. The interquartile ranges (IQRs) of each 
cluster were compared to select cluster(s) whose IQRs were significantly deviated. 
Clusters 3, 4 and 5 revealed significant down regulation compared to the other clusters 
on day 3. The IQRs of those clusters on day 3 were lower than −0.75. Therefore, the 
threshold to select clusters whose expression was significantly changed at a specific 
sampling date was set to the absolute value of 0.75 (see the dashed lines in Figure 2.6). 
A gene pool composing the selected clusters that showed the same expression pattern 
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at the same sampling date was used as a gene-set for gene ontology analysis. As 
shown in Figure 2.6, there is no cluster showing that their IQRs were located at the 
outside of the threshold range (−0.75~ +0.75) on day 1; thus, no gene was selected for 
GO analysis from day 1 samples. However, on day 3, the IQRs of clusters 3, 4 and 5 
were lower than the lower threshold (−0.75), and the genes in these clusters were 
defined as the early/down gene-set because their expressions were decreased. Clusters 
1 and 2 showed a significant increase in their expression on day 5, and the genes in 
those clusters were defined as the late/up gene-set. On the other hand, genes in clusters 
4, 5 and 6 showed significant down-regulation in their expression, and they were 
defined as the late/down gene-set (the dotted boxes in Figure 2.6; Table 2.3. for the list 
of genes in these gene-sets). 
3.4. Identification of statistically overrepresented biological processes 
To predict overrepresented metabolic pathway or biological process that is 
significantly affected by SPS1 knockdown, gene ontology (GO) analysis (Ashburner et 
al., 2000) was performed with 3 gene-sets (early/down, late/up and late/down) 
previously defined using BinGO software (Maere et al., 2005). The parameters for 
statistical test and multiple testing corrections were used to binomical test and 
Bonferroni family-wise error rate (FWER) correction (Benjamini and Hochberg., 
1995), respectively. As a result, total 29 GO biological process terms and 23 genes, 
which are included in each GO term, were selected. (Table 2.4). The terms related to 
vitamin B6 biosynthesis were selected as significant GO terms from the early/down 
gene-set (p-value=2.48e-02). Changing the parameters for statistical tests and multiple 
testing corrections to Benjamini-Hochberg false discovery rate (FDR) (Benjamini and 
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Cluster No. 1 3 4 5
Gene No. 33 genes 9 genes 12 genes 27 genes
Gene Symbol AttB Ac78C CG5210 CG1962 argos Atox1 AlkB CG3950
AttD Adk3 CG7903 CG2065 aub CG10424 armi CG3960
CecB Anxb11 CG8031 CG31274 CG10824 CG11899 Arpc3B CG3961
CG13077 arg CG8051 CG31975 CG13602 CG12014 CG10063 CG4330
CG15526 bab2 CG8147 CG33468 CG15893 CG1218 CG10999 CG4338
CG30484 bgm CG9154 CG9733 CG17834 CG12643 CG12018 CG4502
CG3085 Cat CG9331 Gclc CG31431 CG1572 CG12608 CG4615
CG32170 CG10249 Cyp12a4 PGRP-SB1 CG5144 CG1753 CG12880 CG4953
CG32185 CG12316 Cyp12d1-d Pp2C1 CG9008 CG31472 CG12883 CG5126
CG32625 CG13315 Cyp12d1-p CG9338 CG32280 CG1311 CG6204
CG32714 CG13654 Cyp12e1 pst CG32985 CG13117 CG6659
CG3348 CG13907 Cyp6a14 Tsp42El CG33462 CG1344 CG7381
CG4250 CG14196 Dro CG34008 CG13795 CG7504
CG4259 CG14253 drpr CG3625 CG14079 CG7737
CG5322 CG14629 Drs CG4210 CG14229 CG7995
CG6006 CG16888 egr CG4398 CG14346 CG8157
CG6018 CG17124 fz2 CG5535 CG14872 CG9471
CG6231 CG17186 Gpdh dare CG15083 CG9641
CG8745 CG2003 Gs1 gammaTub37CCG15399 ChLD3
CG9505 CG2794 Idgf1 Hen 1 CG15922 crb
Cyp6a8 CG30046 Idgf2 Hexo1 CG1598 CTPsyn
DptB CG30059 Idgf3 l(2)k16918 CG1628 debcl
eater CG30456 if Mctp CG16790 dnt
Ect3 CG3074 IP3K1 mthl5 CG17129 exu
Mtk CG31075 l(2)01810 Nnf1b CG17181 GNBP3
Oat CG33521 LanB1 numb CG17259 gnu
ome CG3792 nAcRbeta-21C Pgm CG17721 grk
Pepck CG3884 path CG18528 Hexo2
PGRP-LF CG40498 Ror CG2100 ImpL3
PGRP-SD CG4500 Ser CG2177 kek1
pirk CG5630 Spn4 CG2200 ph-p
Pxn CG5793 Thor CG2604 Rcd2
wdp CG5958 tok CG2669 Spn42De
CG6043 Toll-7 CG31142 squ
CG6126 W CG32043 Stlk
CG6199 yellow-f CG32521 Syx4




Table 2.3.  Clusters of DEGs and gene-sets used for gene ontology analysis
77 genes 80 genes
Early / down gene-set










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Hochberg., 1995) and hypergeometric test did not change the results (Figure 2.7), 
suggesting vitamin B6 biosynthesis is the only significant biological process affected 
by SPS1 knockdown at the early stage. GO terms selected from the late/up gene-set 
could be categorized into two distinct biological processes: defense (immune) 
response and carboxylic acid (amino acid) metabolism (Figure 2.8). Both defense 
response (p=6.22e-08) and carboxylic acid processes (p=8.17e-05) were selected with 
significantly high probabilities. Interestingly, 15 genes among 21 genes (72%) selected 
from the late/up gene-set are known to participate in defense response (Table 2.5). In 
addition, 7 of 15 defense response genes encode antimicrobial peptide (AMP). No GO 
term was selected from the late/down gene-set. These results strongly suggest that 
SPS1 affects vitamin B6 biosynthesis at the early stage and then defense response and 
amino acid metabolism through vitamin B6 activity. 
3.5. Validation of expression by quantitative PCR 
Since the cells that were not transfected with double stranded RNA (dsRNA) 
as control for microarray analysis, it was necessary to confirm that the selected DEGs 
have the same expression pattern with the cells transfected with control dsRNA. We 
used GFP dsRNA as a control RNA and quantitative PCR (qPCR) was carried out to 
measure the expression levels. Of 23 DEGs from the selected GO terms (see Table 2.5 
for gene list of selected GO terms), 15 genes were arbitrarily chosen, and their 
expressions were compared between SPS1 knockdown and GFP dsRNA treated 
control cells. The addition of dsRNA of GFP did not show any significant differences 
in the expression of genes when compared to the negative controls to which no dsRNA 
was added. As shown in Figure 2.9, all tested genes showed the same pattern of 
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Max. corrected    p-
value
Selected genes
Early/down Vitamin B6 biosynthesis 2.48E-02 CG11899, CG31472
Late/up Defense response 6.22E-08 AttB*, AttD*, CecB*, DptB*,





Antimicrobial peptides (AMPs) are marked as 
Genes responsible for amino acid metabolism are marked as 
Table 2.5. Representative biological processes selected according to the
common hierarchical ancestor
8.17E-05 arg + , CG8745 + , Gs1 + ,
Oat + , Pepck, yellow-f
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expression as that obtained from microarrays. It should be addressed that all the genes 
involved in vitamin B6 synthesis and encoding AMP were tested and showed the same 
expression patterns. Interestingly, the level of expression between qPCR and 
microarray was significantly different in some AMP encoding genes such as AttB, 
CecB, Drs, DptB and Mtk, and in a gene encoding Pepck that is involved in carboxylic 
acid metabolism, although their expression patterns are similar between microarray 
and qPCR. The relative mRNA amounts measured by qPCR were more than three 
times higher than those obtained from microarray analysis. We assume that the probes 
on microarray against those genes were saturated by the transcripts and accordingly 
the values did not increase proportionally to the amount of RNAs. However, the 
saturation problem can be avoided by qPCR suggesting the values obtained by qPCR 
are more accurate. Therefore, the expression of those genes encoding AMPs was 
increased several hundred folds compared to that in control cell. 
3.6. Intracellular pyridoxal phosphate level was decreased by SPS1 
knockdown 
Because GO analysis predicted that vitamin B6 biosynthesis was the only 
pathway affected at early stage by SPS1 knockdown and the expression patterns of 
genes involved in vitamin B6 synthesis were confirmed, it can be speculated that levels 
of PLP will decrease by SPS1 knockdown. To test this hypothesis, intracellular PLP 
levels were measured after SPS1 knockdown. As shown in Figure 2.10, PLP levels in 
the cells where SPS1 was knocked down decreased by approximately twofold 
compared to the control cells. The PLP concentration in SPS1 knockdown cells was 
37.23±0.66 pmol/mg protein. On the other hand, the PLP levels in the non-treated 
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control and in GFP dsRNA treated cells (negative control cells) were 73.59±1.31 and 
75.37±0.89 pmol/mg protein, respectively. PLP levels in SPS1 knockdown cells were 
similar to those observed in 4-deoxypyridoxine (4-DPN), which is an inhibitor of PLP 
biosynthesis, treated cells (positive control cells). These results indicate that the 
function of SPS1 is to regulate the biosynthesis of PLP in the cells, and also suggest 
that SPS1 can affect PLP requiring reactions such as amino acid metabolisms. It 
should be noted that some DEGs involved in amino acid metabolism were increased in 
their expression after SPS1 knockdown (see Table 2.5) suggesting the lack of PLP in 
the cell provides a signal for compensatory induction of some genes responsible for 
amino acid metabolism. 
3.7. Inhibition of PLP biosynthesis and SPS1 knockdown showed similar 
expression patterns  
Because intracellular PLP levels were significantly reduced after SPS1 
knockdown, it can be assumed that PLP biosynthesis is the primary target of SPS1, 
and the inhibition of PLP synthesis by treating cells with inhibitors will cause similar 
gene expression patterns as those resulting from SPS1 knockdown. To test this 
hypothesis, Drosophila cells were treated with 4-DPN for 5 days, and the expression 
level of genes selected by GO analysis was measured with RT-PCR. As shown in 
Figure 2.11, the level of expression of the early/down genes (CG31472 and CG11899) 
was not changed by 4-DPN treatment. Because 4-DPN inhibits only the function of 
proteins that participate in PLP synthesis and does not affect the expression of genes 
encoding those proteins, it is reasonable that 4-DPN does not affect the expression of 
CG31472 and CG11899. However, the treatment of 4-DPN affected the expression of 
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genes comprising the late/up and late/down gene-sets. Of the 17 genes tested, 14 genes 
(82 %) showed expression patterns similar to those observed by microarray analysis. It 
should be noted that the late gene-sets include genes responsible for defense response 
and amino acid metabolism. These results strongly suggest that PLP synthesis is the 
primary target of SPS1 and that intracellular PLP levels regulate other important 
biological processes such as defense system and amino acid metabolism. 
3.8. The reduction of intracellular PLP level inhibits cell growth and induces 
megamitochondrial formation 
In our previous study, we discovered that SPS1 knockdown leads to cell 
growth inhibition and induction of megamitochondrial formation (Shim et al., 2009). 
As shown in Figure 2.12A, cell growth was significantly inhibited after the cells were 
treated with 4-DPN suggesting that the cell growth retardation induced by SPS1 
knockdown was due to vitamin B6 starvation. Another prominent phenotypic change 
induced by SPS1 knockdown is megamitochondrial formation. Drosophila SL2 cells 
were treated with 4-DPN for 3 days and examined under a confocal microscope after 
the mitochondria were stained with JC-1. As shown in Figure 2.12B, the cells treated 
with 4-DPN formed megamitochondria that were similar to those observed in the 
SPS1 knockdown cells in terms of their size and number. Interestingly, the number of 
polar mitochondria (red dots in Figure 2.12B) in 4-DPN treated cells was similar to 
that in the control cells, and this mitochondrial polarity pattern was also similar to that 
observed in the SPS1 knockdown cells. Since megamitochondria formation can arise 
from several different pathways, we examined whether megamitochondrial formation 
occurred by the activation of Gs1 and l(2)01810. As shown in Figure 2.12C, both the 
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level of Gs1 and l(2)01810 expression was increased. These results strongly suggest 
that the formation of megamitochondria, which is the most prominent phenotype from 
SPS1 knockdown, is induced by the lack of intracellular PLP. 
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4.  DISCUSSION 
We assumed that the genes whose expression was changed at the early stage 
after knockdown are involved in the primary target process regulated by SPS1. To 
identify the primary target, DEGs were isolated after microarray analysis and 
classified according to their temporal expression pattern; GO terms of early changed 
DEGs were analyzed using BinGO software. It is interesting that only PLP 
biosynthesis was predicted from the early/down gene set, even though the parameters 
were changed.  
As shown in Table 2.5, the DEGs in the early/down gene set that are involved 
in vitamin B6 synthesis are CG31472 and CG11899. CG31472 is an ortholog of 
mammalian pyridoxine phosphate oxidase (PNPO), which catalyzes PLP production 
from PMP and PNP and PL production from PN or PM by oxidizing the substrates 
(Musayev et al., 2003). The function of CG11899 was not determined experimentally. 
However, it has high homology with mammalian phosphoserine aminotransferase and 
PdxC of E. coli, which are responsible for producing 4-phospho-hydroxy threonine, a 
precursor of the pyridoxine ring (Drewke et al., 1996). Therefore, it seems that 
CG11899 plays a role in producing precursors of vitamin B6. Interestingly, 
intracellular PLP levels were decreased even though only two genes among four genes 
that are involved in the PLP biosynthesis pathway in Drosophila cell were down-
regulated (Figure 2.13). This result suggests that these two genes are involved in an 
essential step of PLP biosynthesis, or SPS1 may also regulate the other proteins 
involved in PLP biosynthesis post-transcriptionally.  
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Because PLP is used as a cofactor for various enzymes that are important for 
many metabolic pathways, including amino acid metabolism, the inhibition of PLP 
biosynthesis will lead to the inhibition of cell growth. The inhibition of cell growth 
induced by SPS1 knockdown seems to be mediated by a decrease in intracellular PLP 
levels. Specific inhibition of PLP synthesis by 4-DPN treatment led to growth 
inhibition (data not shown), suggesting the growth inhibition by SPS1 knockdown is 
caused by down-regulation of PLP synthesis. 
As described in the Results, down-regulation of genes responsible for PLP 
synthesis stimulated the expression of DEGs that participate in the defense response. 
In addition, most of the late gene-sets showed the same pattern of expression as that 
seen when cells were treated with 4-DPN (Figure 2.11). The relationship between 
vitamin B6 and cellular defense, however, has not been demonstrated before this study. 
Previously, it was reported that the knockdown of SPS1 induced diphthericin 
expression in Drosophila SL2 cell when a genome-wide knockdown was performed 
(Foley et al., 2004). The inhibition of PLP synthesis also induced the expression of 
various AMPs, including dipththericin. Therefore, SPS1 plays a key role in innate 
immune responses, including AMP production, by regulating PLP level in the cell. The 
mechanism by which vitamin B6 regulates the innate immune system remains to be 
elucidated.  
The fact that the treatment of 4-DPN, like SPS1 knockdown, induced 
megamitochondrial formation indicates that intracellular glutamine levels increased 
with the inhibition of PLP synthesis. Because PLP is used as a cofactor for enzymes 
that have transaminase activity, it is reasonable to assume that low levels of PLP will 
lead to the inhibition of synthesis of amino acids such as glutamate or glutamine. 
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However, the inhibition of PLP biosynthesis induced the expression of Gs1 and 
l(2)01810 (Figure 2.12C). These two genes are involved in the increase of intracellular 
glutamine levels (Shim et al., 2009). Interestingly, SPS1 knockdown also induced 
down-regulation of CG1753, which encodes cystathionine β-synthase (Table 2.2). 
Cystathionine β-synthase catalyzes both L-cystathionine and L-selenocysteine 
synthesis (Tamura et al., 2004). In cysteine metabolism, Cystathionine β-synthase 
catalyzes to produce L-cystathionine, which is a precursor compound to be L-cysteine, 
from L-homocysteine and L-serine as substrates (Banerjee, 2005), and cystathionine 
–lyase converts L-cystathionine to L-homocysteine in cysteine catabolism, and also 
L-selenocystathionine to L-selenohomocysteine in selenocysteine metabolism (Mihara 
et al., 1997; Anderson et al., 1979; Flavin and Slaughter 1964). Selenohomocysteine is 
then further transformed into hydrogen selenide. PLP is an essential component of 
these two enzymes (Figure 2.14). Therefore, it seems that SPS1 regulates the synthesis 
of Sec indirectly by regulating the expression of Sec synthesizing enzymes. These 
results suggest that the lack of PLP in the cell provides a signal for compensatory 
induction of some genes responsible for amino acid metabolism. PLP regulation of the 
expression of Gs1 and l(2)01810 has not been elucidated. 
A model for the molecular pathways regulated by SPS1 is summarized in 
Figure 2.14. SPS1 regulates the intracellular level of PLP by regulating the expression 
of genes responsible for PLP biosynthesis. Optimal levels of PLP do not induce 
defense response signaling and glutamine synthesis. However, low levels of PLP 
induce both defense signaling and glutamine synthesis. Once defense signaling is 
stimulated, genes responsible for the innate immune system, including AMPs, are 
activated. The activation of genes responsible for glutamine synthesis leads to 
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megamitochondrial formation. The low level of intracellular PLP also leads to growth 
inhibition, presumably through induction of megamitochondrial formation and/or 
other biological processes. This hypothesis is supported by the observation of cell 
growth inhibition after the treatment of cells with 4-DPN (data not shown). However, 
it is not clear whether the growth inhibition is caused by the induction of both 
glutamine and AMP synthesis or one of these. In our previous study, it was found that 
conditions inducing megamitochondrial formation, such as the over expression of GS1 
and l(2)01810, also resulted in cell growth inhibition (Shim et al., 2009). But there is 
no report showing that the condition for the induction of defense system inhibits cell 
growth. Therefore, the inhibition of cell growth by AMP induction is represented as a 
dotted line in Figure 2.14. 
Although SPS1 was found to regulate the biosynthesis of vitamin B6, the 
mechanism or signal pathway to which SPS1 is related has not been determined. 
Because SPS1 is localized to both plasma and nuclear membranes (Kim et al., 2010), 
it can be speculated that SPS1 regulates signal transduction by transducing signals on 
the plasma membrane or by transporting messengers or transcription factors through 
the nuclear membrane. The treatment of cell with 4-DPN or SPS1 knockdown induced 
the expression of PGRP-SD and Toll-7, which are involved in the Toll signaling 
pathway, and PGRP-LF, which is an activator of the IMD pathway (Figure 2.14). In 
addition, Tamo, which is a negative regulator for nuclear import of Dorsal, was found 
to be one of the down-regulated DEGs. These results strongly suggest that PLP, which 
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1.  INTRODUCTION 
MicroRNAs (miRNAs) are small, non-coding RNA molecules that act as 
post-transcriptional regulators of gene expression by inhibiting translation or 
degrading mRNA genes through partial or complete base pairing with complementary 
sequences of target genes (Bartel et al., 2004). In addition, some miRNAs participate 
in the remodeling of chromatin structures (Yoo et al., 2009). miRNAs are initially 
transcribed as large precursor RNAs, or primary miRNAs (pri-miRNA), and 
sequentially processed by Drosha and Dicer to produce ~22-nucleotide-long active 
mature miRNAs (Lee et al., 2003; Hutvagner et al., 2001; Ketting et al., 2001). 
miRNAs are highly conserved in multiple organisms and play crucial roles in 
development, cell differentiation, determination of cell fate, and cancer (Alvarez-
Garcia et al., 2005; Croce et al., 2005). 
miRNA genes can be classified into two categories according to their 
genomic contexts: intronic and intergenic miRNAs (see Figure 1.21). Intronic 
miRNAs are embedded within other genes. Therefore, they are thought to be 
transcribed by sharing promoters with host genes (Rodriguez et al., 2004). On the 
other hand, intergenic miRNAs are believed to have independent transcription units 
because they are positioned within flanking regions or in antisense orientation to 
annotated genes (Lagos-Quintana et al., 2001). Intronic miRNAs are generally 
believed to be transcribed by RNA polymerase II (pol II); however, it remains unclear 
what type of RNA polymerase is responsible for intergenic miRNA transcription, 
although pol II and RNA polymerase III (pol III) are obvious candidates. For example, 
pri-miR-23a~27a~24-2 and pri-miR-21 are transcribed by pol II and have a 5’-7-
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methylguanosine cap structure and a 3’-polyadenylated [poly(A)] tail similar to the 
structure of mRNAs (Lee et al., 2004; Cai et al., 2004), while miR-517a and miR517c, 
which are interspersed among Alu repeats in the human chromosome 19, are 
transcribed by pol III (Borchert et al., 2006).  
The transcriptional start site of intergenic miRNA genes usually occurs 
within 2 kb upstream from the start site of miRNAs (Saini et al., 2007). Using 
computational methods, several conserved sequence patterns for intergenic miRNA 
genes, including putative promoters, have been proposed from various species (Zhou 
et al., 2007; Heikkinen et al., 2008). Among these, CT repeats are most well known. 
They are highly conserved among four species, such as Caenorhabditis elegans, 
Homo sapiens, Arabidopsis thaliana and Oryza sativa, and are abundant within 1000 
bp upstream sequences from miRNA hairpins (Zhou et al., 2007). Another sequence 
pattern, GANNNNGA, was identified within 1000 bp upstream of worm miRNAs 
(Heikkinen et al., 2008). However, there is no direct evidence that these conserved 
patterns play a role as promoter or regulatory elements. Currently, the transcriptional 
mechanisms of most intergenic miRNAs are largely unknown. 
Epigenetic signatures such as DNA methylation and histone modification, 
and the regulation of expression of miRNA genes are tightly linked similarly to other 
genes (Heintzman et al., 2007; Ozsolak et al., 2008; Suzuki et al., 2011; Toyota et al., 
2008, see Figure 1.22). For example, chromatin signatures such as trimethylation of 
histone H3 at lysine 4 (H3K4me3) and acetylation of histone H3 at lysines 9 and 14 
(H3K9/14Ac) are established as markers for transcriptionally active promoters (Li et 
al., 2007; Okitsu et al., 2010), whereas trimethylation of histone H3 at lysine 27 
(H3K27me3) is characterized as a marker for transcriptional repression (Kahlil et al., 
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2009). Recently it was reported that hypermethylation of the human miR-124 loci, 
which is the most abundant miRNA in the adult brain and plays a key role in 
neurogenesis, inhibits miR124a expression and results in brain tumors (Agirre et al., 
2009; Cao et al., 2007; Silber et al., 2008). Interestingly, some miRNAs control the 
expression of epigenetic regulators, including DNA methyltransferases and histone 
deacethylases (Fabbri et al., 2007; Noonan et al., 2009). The fact that miRNA gene 
expression can be regulated by DNA methylation indicates the feasibility of using 
methylated sequences to predict miRNA gene promoters or regulatory elements.  
In this study, to identify the putative transcriptional regulatory elements for 
concering with the intergenic miRNA expresseion, we tried to analysis with various 
bioinformatical tools, such as motif search, for the data retrieved from methyl-binding 
domain (MBD)-chip array experiments. Then we found a novel sequence motif, 
C[N]6CT, for intergenic miRNA gene expression by predicting sequence patterns in 
the differentially methylated regions (DMRs), and by examining the relationship 
between the occurrence of this motif and methylation dependence of gene expression. 
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2.  MATERIALS AND METHODS 
2.1. Cell lines and culture 
H4 cells, a human neuroglioma cell line, were purchased from the American 
Type Culture Collection and cultured in Dulbecco’s modified Eagle’s medium 
(DMEM; Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum 
(FBS; Invitrogen, Carlsbad, CA, USA) and 1% antibiotics-antimycotics (Invitrogen, 
Carlsbad, CA, USA) at 37C in a humidified incubator containing 5% CO2 
2.2. Identification of miRNAs from sequence and annotation data 
The genomic coordinates of 1,049 human miRNAs were obtained from the 
miRBase (ver. 16.0) (Griffiths-Jones et al., 2006), and all sequences and the annotated 
data were from the UCSC genome browser (http://genome.ucsc.edu). A total of 1,049 
miRNAs were classified into 621 intronic and 428 intergenic miRNAs according their 
genome contexts.  
2.3. Probe design  
Sequences up to 1,000 bp upstream from the start site of 428 intergenic 
miRNAs were retrieved and cleaved into 60-bp-long sequences overlapped by 40 bp 
of adjacent sequence (Figure 3.1). Chopped sequences were filtered based on 
sequence redundancy, low GC ratios (GC ratio < 0.6), and low melting temperatures 
(Tm < 85C). A total of 7,646 sequences were selected as probes for printing on an 
122
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Agilent 15K array platform to build a customized array chip (Chip No. 
253347810001).  
2.4. Microarray experiment 
Genomic DNA was isolated from H4 cells cultured in the presence or 
absence of 5 μM 5-aza-2-deoxycytidine (DAC), an inhibitor of DNA 
methyltransferase. Briefly, after sonicating the genomic DNA (0.5 μg), the fragments 
were incubated with 2 μg recombinant methylation-specific binding protein (MBD2bt) 
at 4°C for 4 h on a rocking platform. The enriched methylated DNA was amplified 
using a Whole Genome Amplification Kit (GenomePlex®, Sigma-Aldrich, St. Louis, 
MO, USA) as recommended by the manufacturer’s instructions. The amplified DNA 
from DAC-treated and untreated cells were labeled with cyanine 5 (Cy5) and cyanine 
3 (Cy3), respectively. The labeled DNA samples were purified using a PCR 
Purification Kit (QIAquick, Qiagen, Valencia, CA, USA) and co-hybridized to the 
customized microarrays according to the manufacturer’s protocol. The microarrays 
contained a total of 7,646 oligonucleotide probes, including control probes and those 
covering the sequences upstream of the miRNA genes (Figure 3.2).  
2.5. Microarray data analysis 
The hybridized images were analyzed using an Agilent DNA Microarray 
Scanner (Agilent Technology, Palo Alto, CA, USA) and data quantification was 
performed using Feature Extraction software version 10.7.3.1 (Agilent Technologies, 
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performed using R software (http://www.r-project.org). Background-corrected 
intensity data were normalized using the intensity-dependent LOWESS method to 
remove the dye bias within each array. The p-values for each probe were calculated 
using linear fit models implemented in the Limma package (http://bioconductor.org/ 
packages/release/bioc/html/limma.html), and the probes within the threshold (p-value 
< 0.05) were selected as differentially methylated probes (DMPs). Since the probes 
were designed to 40-bp overlapped with each other, overlapped DMPs were 
constructed to be a contig, called differentially methylated regions (DMRs) 
2.6. Distribution analysis 
2.6.1.Predicted transcription factor binding sites (TFBSs) 
Conserved transcription factor binding sites (TFBSs) were identified in the 1-
kb region upstream of 1,049 miRNAs using PROMO (Messenguer et al., 2002), a 
web-based program to predict putative TFBSs in DNA sequences. PROMO uses the 
TRANSFAC database to construct specific binding site weight matrices for TBFS 
prediction. Many TFs are provided as a list in the TRANSFAC database, enabling us 
to restrict the prediction to TF sets or to use all TFs. The general transcription factors 
TFIIB and TFIID, which recognize TATA box, and TFII-I, which binds to a 
pyrimidine-rich initiator (Inr) and a recognition site (E-box) for upstream stimulatory 
factor 1 (USF1), were used to predict the TFBSs.,  
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2.6.2. Predicted transcription start sites (TSSs) 
TSSs were searched for in the same region as TFBSs using with the 
application implemented Eponine method (Down et al., 2002), a probabilistic method 
for detecting TSSs in mammalian genomic sequence. The default Eponine threshold of 
0.990 was used because this threshold generally provides a useful number of 
predictions without sacrificing accuracy.  
2.6.3. DMRs 
Distribution curves were drawn with the number of DMRs, TFBSs, and TSSs 
calculated by scanning in a 40-bp window. The counted data were transformed to a 
standard normalized value because the number of probes for intragenic and intergenic 
miRNA, as well as predicted TFBSs and TSSs, were substantially different, making it 
difficult to compare them in a single plot. All analyses were performed using R 
software (http://www.r-project.org). 
2.7. Motif analysis 
2.7.1. Multiple alignments of DMRs and clustering 
Alignment of DMR sequences was performed using ClustalX (ver. 2.0.12) 
software (Larkin et al., 2007) with the default parameters. A phylogeny tree was 
constructed based on the Neighbor-joining (NJ) model (Saitou et al., 1987) using 
MEGA5 (Tamura et al., 2011) with the following parameters: substitution model was 
127
set to maximum composite likelihood, missing data treatment was set to partial 
deletion, site coverage cutoff was from 100% to 95%, and the other parameters were 
set at default. 
2.7.2. Identification of statistically significant motifs 
MEME (Bailey et al., 2006) was used to search for top-ranking degenerate 
motifs within the probe sequences in each cluster, and its optional parameters were set 
to as follows: optimum motif width was set to 8-12 bp, occurrence of motif in the 
input sequences was set to any number of repetitions in the input sequence, and others 
parameters were left as default. The MEME algorithm calculates the significance of 
each identified motif against random sequences with the same nucleotide composition, 
and assigns an E-value based on the probability of obtaining the observed number of 
motifs. 
2.8. Reverse transcription PCR reaction  
Total RNA was isolated using the RecoverAll, Total Nucleic Acid Isolation 
Kit (Ambion, Austin, TX, USA), according to the manufacturer’s protocol. RNA 
quantity and purity was determined using the NanoDrop 1000 spectrophotometer 
(Thermo Scientific, Rockford, IL, USA). Reverse transcription was performed using 
the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems, Foster City, 
CA, USA). All reactions were performed as per the manufacturer’s protocol. Rnu6b 
was used as a negative control. 
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2.9. Quantitative real-time PCR 
Quantitative real-time PCR was performed to amplify miRNAs with specific 
primer sets against target miRNAs (Applied Biosystems, Foster City, CA, USA) using 
the ABI-7500 Real Time PCR system according to the manufacturer’s protocol. 
Template (10 ng) was amplified in 20 l reaction volumes. PCR conditions were as 
follows: 50C for 2 min, 95C for 10 min, 50 cycles of 95C for 15 s, and 60C for 1 
min. Experiments were performed in triplicate. 
2.10. miRNA targets prediction 
Target genes for selected intergenic miRNAs were predicted by using 
miRanda open source software (http://www.microrna.org/microrna/) associated with 
the miRBase with a cutoff p-value less than 0.05. Common target genes of selected 
intergenic miRNAs were extracted and input for GO analysis.  
2.11. Gene ontology analysis 
GO analysis was performed by BiNGO version 2.3 (Maere et al., 2005), 
which is plugged in Cytoscape (Shannon et al., 2003). Gene symbols of predicted 
target genes were used as input data. The parameters were set as follows: assessment 
was set to overrepresentation, statistical test to binomial test, multiple testing 
correction to FDR correction, significance level to 0.05. The most significant pathway 
was predicted by considering the selected GO terms and visualized output.  
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2.12. Analysis of bisulfate sequencing data 
The raw data of bisulfate sequencing were obtained from GEO database 
(Accession number: GSE15007). The number of three types of motifs within reads, 
C[N]6CT, T[N]6CT, and C[N]6TT, were counted by a customized Perl scripts. Mapping 
of bisulfate sequencing reads was performed with chromosome 12 and 20 using 
BSMAP web tools. The position of C[N]6CT motif in chromosome 12 and 20 were 
determined whether the reads corresponding to the bisulfate-converted strand or the 




3.  RESULTS 
3.1. Identification of DMRs 
To identify DMRs in the upstream of miRNA genes, microarray analysis was 
performed using our custom chips. A total of 7,646 probes against the 5’-flanking 
region of 428 intergenic miRNA genes were designed (Figure 3.1) and implemented 
on the Agilent 15K array chip platform. Genomic DNA was isolated from H4 cells 
cultured in the absence or presence of 5-aza-2-deoxycytidine (DAC). Methylated 
sequences were enriched using MBD2bt proteins. The methyl group-enriched DNAs 
were labeled with fluorescent dyes and then hybridized with the probes on chips (see 2. 
Materials and Methods in this chapter).  
The signal intensities of the 7,646 probe spots on each chip were obtained 
after LOESS normalization. The Pearson’s correlation of signal intensities between 
chips was 0.99 (Figure 3.3A). By performing a linear fitting and Bayes function 
analysis, a total of 161 probes (adjusted p-value < 0.05) were found to have different 
methylation levels between DAC-treated and untreated samples (Figure 3.3B) and 
these were defined as differentially methylated probes (DMPs). These DMPs were 
derived from 98 intergenic miRNAs. The sequences of the DMPs are shown in Table 
3.1.  
3.2. Distribution of DMRs, TFBSs and TSSs 
To determine the distribution of the DMPs on the 5’-flanking region of each 
gene, we calculated the relative distance of DMPs from the 5’-end of each intergenic 
131
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miRNA and constructed a frequency graph for DMPs in 200-bp intervals. As shown in 
Figure 3.4, the majority of DMPs were located within 400 bp upstream from the start 
site of each miRNA, suggesting that the major DMR, which is defined as the contig of 
DMPs, overlaps with the region containing the transcriptional regulatory elements 
such as promoter and proximal sequence elements. Interestingly, there is an additional 
DMR (20.9% of total DMPs) spanning from -800 to -1,000 where enhancers are 
usually found.   
The sequence elements responsible for gene expression are closely regulated 
by methylation, therefore, we also screened for the distributions of TFBSs and TSSs 
upstream of the miRNAs. We searched 1 kb upstream of 1,049 human miRNAs to 
find TFBSs and TSSs using PROMO (ver 3.0) (Messequer et al., 2002) and Eponine 
(Down et al., 2002), respectively, as described in the Materials and Methods.  
A total of 2,457 predicted TFBSs and 1,346 predicted TSSs prediction were 
identified. The majority of predicted TFBSs (n = 1406; 57.2% of the total) and TSSs 
(n = 905; 67.1% of the total) were upstream of intergenic miRNAs, which is consistent 
with a previous study showing that predicted TSSs are mainly distributed within 2 kb 
upstream of the intergenic miRNAs (Bracht et al., 2004). As shown in Figure 3.5, 
TFBSs were abundant at 170–230, 300–470, 680–780, and 850–960 bp upstream (blue 
bar in Figure 3.5), and TSSs were located at 50–250 bp upstream from the pre-miRNA 
starting site (blue-dotted bar in Figure 3.5). It is noteworthy that the regions upstream 
of intergenic miRNAs that were enriched for TFBSs and TSSs were generally 
overlapped with highly methylated regions, suggesting that these regions may be 
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3.3. Clustering DMRs using phylogenetic method 
We predicted that most or all of the DMR sequences could be clustered by 
their sequence similarities to identify specific miRNA regulatory motifs. To test this 
prediction, DMR sequences were aligned using clustalX (Larkin et al., 2007), and a 
phylogenetic tree was constructed based on the NJ model (Saitou et al., 1987) using 
MEGA5 (Tamura et al., 2011). 
Analysis of the DMRs of the intergenic miRNA revealed that the DMRs 
were clustered into eight distinct clusters in the tree structure, which was constructed 
with site coverage cutoff at 99% (Figure 3.6). Clusters 2 and 5 were the largest, 
containing 37 and 31 DMRs, respectively. The number of the DMRs in clusters 1, 3, 4, 
6, 7, and 8 were 16, 22, 22, 10, 6 and 17, respectively. When performing multiple 
sequence alignment with 161 DMPs using the ClustalX program (Larkin et al., 2007), 
only a single consensus sequence, CNNNNNNC (C[N]6C), was found in all DMPs, 
which was also composed of conserved cytosine residues at position 1 and 8 and 
almost equal frequencies of different nucleotides in positions 2 to 7 (Figure 3.7).  
3.4. Prediction of sequence motifs from DMPs 
Because altering genome DNA methylation usually affects the efficiency of 
gene expression, it can be assumed that a specific sequence motif that regulates the 
transcription of its target miRNA gene is located within DMRs. Therefore, we 
analyzed the DMP sequences to predict a sequence motif using MEME software 
(Bailey et al., 2006), which is used to predict statistically overrepresented sequence 
motifs. 
141
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 After performing MEME with DMP sequences, we obtained six significant 
sequence patterns (p-value < 1.00e-05; Figure 3.8) which were 8–11 bp long. The 
most significantly overrepresented pattern was CNNNNNNCT (C[N]6CT, p-value = 
3.22e-18). N designates a non-conserved nucleotide. CTANCCTC, CTCTNCNC, 
TCTNNNTNT, GAGGTNTGATC, and CNNAGNGAC were also selected as 
significant patterns, the p-values of which were 2.15e-07, 5.26e-07, 2.34e-05, 2.80e-
05, and 8.22e-05, respectively. It should be noted that there was a significant 
difference between the p-values for the C[N]6CT pattern and CTANCCTC (11 
logarithmic order), suggesting that C[N]6CT is a major sequence motif in DMRs. 
Interestingly, CTANCCTC and CTCTNCNC patterns, as well as C[N]6CT, contain 
two cytosine residues at positions 1 and 8, suggesting the cytosine residues at these 
positions are important for these patterns. It should be noted that this C[N]6CT motif is 
highly similar to the C[N]6C pattern performed by multiple alignment. These results 
suggest that the two conserved cytosine residues at positions 1 and 8 are likely 
embedded in the regulatory elements, and that the C[N]6CT pattern may be a potential 
regulatory motif for intergenic miRNA gene expression. Thus, we selected the 
C[N]6CT pattern as a candidate motif of regulatory element for intergenic miRNA 
expression. 
We next examined the C[N]6CT pattern within 1000 bp upstream of 98 
intergenic miRNAs that contain DMPs, and identified a total of 1,766 C[N]6CT motifs. 
Among the 1,766 C[N]6CT motifs, 189 (10.7%) were located in DMPs (Table 3.2). 
Overall, the number of C[N]6CT motifs found in DMPs is small compared to that 
found in non-DMPs. However, further analysis of this motif showed that each gene 
contains a different frequency of C[N]6CT motifs in its DMPs. For example, miR-
144
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200c has three DMRs, and 16 out of 22 C[N]6CT motifs (72.7%) are concentrated in 
the DMRs (top line in Figure 3.9). In miR-124-1, there are four largely methylated 
regions that contain 11 out of 28 C[N]6CT motifs (39.3%) (middle line in Figure 3.9). 
On the other hand, miR-92b contains three methylated regions, but there is no 
C[N]6CT motif in these regions (bottom line in Figure 3.9). 
3.5. Effect of demethylation on intergenic miRNA expression 
 It is important to determine whether the expression level of intergenic 
miRNA changes depending on the frequency of C[N]6CT motifs in DMRs. Therefore, 
we first treated H4 cells with DAC to demethylate DNA. Then we isolated total RNA 
and measured the expression levels using quantitative PCR analysis against eight 
selected intergenic miRNA genes: one miRNA which had the highest frequency of 
C[N]6CT motifs in DMRs (miR-200c), two with a 30–40% frequency (miR-124-1, 
miR-375), two with a 20–30% frequency (miR-34c, miR-210), one with a 10–20% 
frequency (miR-212), and two with less than 10% frequency (miR-3188 and miR-92b), 
all of which had more than three DMRs in their upstream regions but had no or only 
one C[N]6CT motif in the DMRs (Table 3.2). Rnu6b was used as a negative control. 
As shown in Figure 3.10, the expression levels of six of eight intergenic miRNAs 
(miR-200c, miR-124-1, miR-375, miR-34c, miR-210, and miR-212) increased 
significantly in DAC-treated cells compared to untreated normal cells. The expression 
level of miR-200c, which shows the highest frequency of C[N]6CT motifs in DMRs 
(72.7%), was increased by 22.3-fold after DAC treatment. The expression levels of 
miR-124-1, miR-375, miR-34c, miR-210, and miR-212 were also increased by 11.3, 
9.4, 8.4, 3.5, and 13.2-fold after DAC treatment, respectively. On the other hand, DAC 
149
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treatment did not significantly change the expression levels of miR-92b or miR-3188. 
It should be noted that the frequencies of the C[N]6CT motif in the DMR of miR-92b 
and miR-3188 are less than 10%, although they have more than three DMRs. These 
results strongly suggest that the frequency of C[N]6CT motifs in DMRs is related to 
intergenic miRNA expression. 
3.6. Correlations between the C[N]6CT motif in DMRs and intergenic 
miRNA expression 
Because the expression of intergenic miRNA genes were changed after DAC 
treatment in a motif-frequency dependent manner, we analyzed the relationship 
between the frequency of the C[N]6CT motif in DMRs and the expression of 
intergenic miRNAs induced by demethylation. Correlation analysis between the fold 
changes of gene expression and the frequency of C[N]6CT motifs in DMRs was 
performed with the eight miRNA genes described in the previous section. After 
performing Pearson’s correlation test using those miRNAs, we obtained a high 
correlation value of 0.87 (p-value = 4.3e-03) between the frequency of C[N]6CT 
motifs in DMRs and the fold changes in miRNA expression after demethylation 
(Figure 3.11). These results indicate that the frequency of C[N]6CT motifs in DMRs 
plays a role in the expression efficiency of intergenic miRNAs in conjunction with the 
methylation status, and strongly suggests that the C[N]6CT sequence pattern in DMRs 
is a methylation-dependent regulatory motif for intergenic miRNA expression. 
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4.  DISCUSSION 
After identifying 161 DMPs within 1000 bp upstream of human intergenic 
miRNAs using microarray analysis, we searched for motifs within the DMRs and 
found a sequence motif, C[N]6CT, which is conserved in the DMRs. Previous studies 
have reported that CT-repeat microsatellites are abundant within 1000 bp upstream of 
most intergenic miRNA (Zhou et al., 2007 and references therein). Some motifs 
containing CT-repeats, including (CCT)n, (CCTT)n, (CGCT)n, and (CCTCT)n, have 
previously been identified in plants (Fujimori et al., 2003; Molina et al., 2005). 
Among these, the (CCT)n and (CCTCT)n motifs are very similar to the C[N]6CT motif, 
which have two cytosine residues at positions 1 and 8. In other words, when n equals 3 
in (CCT)n, the sequence of the motif will be CCTCCTCCT, which can be represented 
as C[N]6CT. Similarly, (CCTCT)n can also be represented as CC[N]6CT when n 
equals 2. Therefore, the C[N]6CT motif is highly similar to (CCT)n and (CCTCT)n.  
Generally, promoters contain mehylated CpG islands is well understood in 
long-term silencing of genes (Lin et al., 2007; Jones et al., 1999). Despite the fact that 
45% of all human gene promoters, particularly those controlling the expression of 
tissue-specific genes, do not lie within CpG islands (Takai et al., 2002), is almost 
unknown about their regulation and the potential role of methylation as a 
transcriptional control mechanism. A number of genes with non-CpG island promoters 
have been reported to be methylated in normal tissues, displaying a tissue-specific 
methylation pattern, suggesting DNA methylation may play a role in the establishment 
and maintenance of tissue-specific expression patterns (Eckhardt et al., 2006). Some 
studies have shown that there is an inverse correlation between DNA methylation and 
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gene expression, as it has been demonstrated for CpG island promoters (Eckhardt et 
al., 2006; Gal-Yam et al., 2008; Han et al., 2011), where other studies have reported 
that CpG-poor promoters could be still expressed when they are methylated (Weber M. 
et al., 2007). Moreover, Barres et al have reported that the non-CpG methylation level 
was highly enriched on the promoters of PGC-1 and TFAM compared to global 
levels (Barres et al., 2009). They showed that 7% of cytosines within the sequence 
CCAGG or CCTGG are methylated in human skeletal muscle suggests that further 
attention should be given to non-CpG methylation when using current DNA 
methylation analysis techniques.  
The C[N]6CT motif must be located in DMRs to play a role as a regulatory 
element because the expression was increased in the genes with high frequency of the 
C[N]6CT motif in DMRs after DAC treatment. For examples, the mir-200c/141 cluster 
and mir-124-1 genes are functionally involved in carcinogenesis regulated by DNA 
methylation-based silencing (Neves et al., 2010; Hashimoto et al., 2010; Wilting et al., 
2010). The majority of DMRs in these genes were found within 400 bp and 800–1000 
bp upstream from the start sites of each miRNA, and the C[N]6CT motif was also 
predominantly found in these regions. It is possible that the cytosine residues at 
positions 1 and 8 of the C[N]6CT motif in DMRs are methylated because they are 
found in methylated regions. The fact that this motif is associated with the expression 
of intergenic miRNA genes in a motif-frequency dependent manner suggests that the 
C[N]6CT motif regulates gene expression by methylation/demethylation of cytosine.  
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Our findings indicate that the C[N]6CT motif is closely associated with DNA 
methylation regions and might be a regulatory factor binding site or recognition 
sequence for miRNA processing. Combining DNA methylation signature with the 




















1.  CONCLUSIONS 
Microarray technology is widely used in various biological researches such 
as finding gene functions by measuring expression profiles, detecting genetic variation 
among populations, and epigenetic analysis. Especially, microarrays are very useful 
tool because the expression levels of thousands of genes can be monitored 
simultaneously. However, the prediction accuracy that can be obtained from 
microarrays is dependent on the statistical methods and the several bioinformatical 
approaches including gene clustering, GO analysis.  
For example predicting gene function, we used SPS1 which functions are 
unknown yet, and predicted that vitamin B6 biosynthesis is the primary target of SPS1 
by employing two-way ANOVA, SOM clustering and GO analysis. We confirmed the 
prediction experimentally by showing that PLP levels were decreased by SPS1 
knockdown and that the inhibition of PLP biosynthesis caused the same phenotypes as 
SPS1 knockdown.  
For example for predicting regulatory elements, we selected intergenic 
miRNAs because the transcriptional mechanism of intergenic miRNAs is not well 
understood. Microarray data is also used to identify the differentially methylated 
regions of intergenics miRNAs by statistical methods. We found that the regulation of 
gene expression by C[N]6CT motif is closely associated with DNA methylation status 
and the frequency of C[N]6CT motif occurrence in DMRs of intergenic miRNA gene. 
This motif may be a regulatory factor binding site for transcription factors or 
demethylase.  
We showed that analysis of microarray data using bioinformatical approaches 
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is very useful to predict gene functions and regulatory elements. Though microarray 
techonolgy can give high-throughput, high-density information, it is still difficult for 
researchers to plan and decide the various parameters and options associated with 
microarray data analysis. However, the combinatorial analysis of various 
bioinformatical tools and statistical models for analyzing microarray data will give us 
more precisely predicted information for biological problems. Nowdays, new high 
throughput sequencing, or next generation sequencing (NGS), technology, is 
developed and widely used for lots of research areas, such as genomics, 
transcriptomics, physiomics and so on. More powerful and obvious results for 
biological interpretation can be served by the bioinformatical prediction and analysis 
using both high-throughput technologies in the future. 
2.  FURTHER REMARKS 
 In prediction of transcriptional regulatory elements using intergenic miRNAs, 
we found that the C[N]6CT motif in DMRs can act as a transcriptional regulatory 
motif for intergenic miRNA expression. However, there are no direct evidences 
whether conserved cytosine residues positioned at 1 and 8 are methylated or not. 
Generally, it is though that DNA methylation is occurred within CpG islands in 
human, although it has been reported that some DNA methylation is found on non-
CpG regions recently. For these reasons, bisulfide sequencing have to be performed to 
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생물정보학은 대량의 데이터를 컴퓨터 기술과 통계적 이론을 통해 
생물학적 의미를 해석하고 예측하는 중요한 생물학의 한 분야이다. 
마이크로어레이 기술의 발전으로 대량의 연구 결과가 축적됨에 따라 이를 
생물정보학적 방법을 통해 분석하여 유전자의 기능 및 조절 서열을 
예측하고자 하는 연구가 활발히 진행되고 있다. 이 논문에서는 
생물정보학적 방법으로 마이크로어레이 자료를 분석하여 셀레늄 인산 
합성효소 1 (SPS1)의 유전자의 기능과 마이크로RNA의 전사조절인자에 대한 
예측과 실험적으로 검증한 연구 결과를 제시한다. 
마이크로어레이 데이터를 이용하여 유전자의 기능을 예측한 연구는 
Sps1 유전자를 모델로 이용하였다. 고등 진핵생물에는 두 가지 형태의 
셀레늄 인산 합성효소 (SPS), 즉 SPS1과 SPS2가 존재하는데, 두 가지 
형태의 효소 가운데 단지 SPS2만이 셀레늄 인산 합성반응을 촉매 하는 
것으로 알려져 있으며, SPS1의 기능은 아직 명확하지 않다. 그러나, SPS1은 
세포의 성장과 배아 발달 등 세포 활동에 필수적인 기능을 가진 것으로 
알려져 있다. 따라서, SPS1의 세포 내 기능을 생물정보학적 방법을 
이용하여 예측하고 실험적으로 확인하였다. 초파리 세포를 이용하여 Sps1 
유전자의 발현을 억제시키고 각각 1, 3, 5일이 경과한 후에 메신저RNA을 
분리하여 마이크로어레이 실험을 통해 정상과 차이를 보이는 유전자를 
이원분산분석법을 통해 동정하였다. 선별된 유전자들을 시간에 따라 
변화되는 발현량의 차이를 SOM 클러스터링 방법으로 3x2 그리드에서 
클러스터링한 후, 초기와 후기에 발현이 변하는 유전자들을 이용하여 
유전자셋을 만든 후, 이들이 가지는 생물학적으로 유의한 기능을 gene 
ontology (GO)를 이용하여 통계적으로 유추하였다. GO 분석 결과 비타민B6 
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합성에 관여하는 유전자가 가장 초기에 (Sps1 유전자 발현 억제 후 3일 째) 
유의한 변화를 보이는 것을 발견하였고, 후반부에는 (5일 째) 아미노산 
대사 및 면역과 관련된 유전자들의 변화가 크게 나타나는 것을 관찰할 수 
있었다. GO분석 SPS1의 일차 타깃이 비타민B6의 합성과 관련되어 있다는 
예측 결과를 실험적으로 검증하였다. 흥미로운 점은 SPS1의 발현을 
억제시켰을 때, 이미 보고된 바와 같이 거대 미토콘드리아 표현형을 보인 
연구 결과와 동일한 표현형을 보임과 동시에 비타민B6의 활성 형태인 
피리독살인산 (PLP)의 농도가 또한 현저히 감소되는 것을 확인하였다. 
아울러 PLP 농도를 인위적으로 감소시켰을 때, SPS1 유전자의 발현을 
억제한 경우와 매우 유사하게 아미노산 대사와 면역에 관련된 유전자들의 
발현이 감소되는 현상을 보였다. 이러한 결과를 통해 SPS1이 
아미노산대사와 면역과 같은 세포 내 중요한 대사 활성에 영향을 주는 
비타민B6의 합성을 조절하는 기능을 하고 있음을 증명하였다.  
생물정보학적으로 유전자 발현을 조절하는 조절 서열을 예측은 
마이크로RNA를 모델로 연구하였다. 마이크로RNA는 표적 유전자들이 
단백질로 번역되는 과정을 조절하는 중요한 전사 후 조절 기능을 하는, 
평균 22염기로 이루어진 짧은 RNA분자이다. 이들은 알려진 유전자의 내부 
서열에 존재하는 인트로닉 마이크로RNA와 유전자가 존재하지 않는 지역에 
독자적으로 존재하는 인터제닉 마이크로RNA로 크게 구분되는데, 인트로닉 
마이크로RNA의 경우, 그들이 속해 있는 호스트 유전자의 발현 조절인자를 
공유하여 발현되는데 반해, 인터제닉 마이크로RNA의 발현에 대한 기작은 
아직 완전히 이해하지 못하고 있다. 따라서, 인터제닉 마이크로RNA에 대한 
프로모터 또는 조절 서열을 예측하기 위하여 후생유전학 정보, 특히 DNA 
메틸화 정보를 이용하였다. 신경교종세포의 마이크로RNA의 상부 1kb 
부위에서 메틸화가 많이 되어 있는 부위를 마이크로어레이 기술을 
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이용하여 동정한 후, 이들 서열을 다량서열정렬방법과 모티프 검색방법을 
적용하여 통계적으로 매우 유의한 결과를 보이는 C[N]6CT 모티프 서열을 
발견하였다. 인터제닉 miRNA들의 1 kb 상위 서열에서 C[N]6CT 모티프 
서열의 분포를 조사한 결과, 이 모티프가 메틸화가 많이 되어 있는 부위에 
밀집되어 존재하는 miRNA에서부터 그렇지 않은 miRNA에 이르기까지 
다양한 양상을 보였다. 이 모티프가 인터제닉 마이크로RNA의 발현에 
관여한다는 사실을 증명하기 위해 실험적 검증을 진행하였다. 메틸화 
서열에 C[N]6CT 모티프 서열이 가장 많이 밀집되어 있는 has-mir-200c를 
비롯하여 메틸화 서열에서 이 모티프를 하나도 포함하지 않는 has-mir-3188 
등 8개의 인터제닉 miRNA들을 이용하여 메틸전이효소 억제제를 처리한 
전후에 발현 정도를 qPCR를 통해 실험적으로 측정하여 본 결과, 메틸화가 
된 부위에 C[N]6CT 모티프 서열의 출현 빈도가 높은 인터제닉 
마이크로RNA의 발현은 크게 증가하는 양상을 보인 반면, 빈도가 낮은 
인터제닉 마이크로RNA의 경우 그렇지 못했다. 마이크로RNA의 발현과 
메틸화된 부위에서의 C[N]6CT 모티프 서열의 밀집 정도에 대해 피어슨 
상관분석을 통해 분석한 결과, 상관계수가 0.87로 매우 밀접한 상관관계가 
있음을 보여 주었다. 이 연구 결과는 DNA 메틸화와 밀접히 관련된 
C[N]6CT 모티프 서열을 발견함으로서 이 모티프가 인터제닉 
마이크로RNA의 발현 조절과 밀접한 관련이 있음을 생물정보학적인 
방법으로 예측하였으며, 또한 새로운 인터제닉 마이크로RNA의 발견을 
위한 중요한 단서를 제공해 주는 결과이다.   
마이크로어레이 자료를 이용하여 생물정보학적 방법을 통해 
유전자의 기능과 전사 조절인자의 예측에 대한 두 가지 예측 연구를 
진행하고 이를 확인한 결과, 예측 결과가 매우 정확성이 높음을 확인할 수 
있었다. 이는 지금까지 개발된 다양한 생물정보학적 이론의 적절한 조합을 
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통해 보다 높은 확률로 여러 가지 연구 분야에 적용할 수 있음을 말해주는 
연구 결과이다. 최근에는 차세대서열분석이라는 새로운 기술이 등장함에 
따라, 마이크로어레이를 통한 생물학적 연구가 다소 사양되고 있으나, 두 
가지 기술을 병행하여 다양한 생물정보학적 도구 및 모델을 적용시켜 
분석한다면 보다 정확하고 생물학적으로 의미있는 해석을 위한 결과를 
도출할 수 있을 것으로 기대한다.  
 
주요어 : 셀레늄인산 합성효소 1, 비타민B6, 마이크로RNA, 프로모터 
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